<!DOCTYPE html>
<html class="no-js" lang="en" dir="ltr" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/terms/" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:sioc="http://rdfs.org/sioc/ns#" xmlns:sioct="http://rdfs.org/sioc/types#" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:schema="http://schema.org/" xmlns:fb="http://ogp.me/ns/fb#">

<head>
  <!-- Set gtm id codes for various environments. -->

	<!-- Google Tag Manager -->
	<script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
	new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
	j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
	'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
	})(window,document,'script','dataLayer','GTM-W3ZV');</script>
	<!-- End Google Tag Manager -->
  <meta charset="utf-8">
    <title>Consent forms for SACT (Systemic Anti-Cancer Therapy) | Cancer Research UK</title>

  <script charset="UTF-8" src="//cdn.cookielaw.org/scripttemplates/otSDKStub.js" data-domain-script="81232513-709c-4b95-8a41-a4b812c22fdc" async=""></script>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
<link rel="shortcut icon" href="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/favicon.ico">
<link href="/sites/all/themes/custom/cruk/fonts/cruk-icons/CRUKIcons.woff" rel="preload" as="font" crossorigin="1">
<link href="/sites/all/themes/custom/cruk/fonts/museo/MuseoSansRounded-700.woff2" rel="preload" as="font" crossorigin="1">
<link href="/sites/all/themes/custom/cruk/fonts/museo/MuseoSansRounded-500.woff2" rel="preload" as="font" crossorigin="1">
<link href="/sites/all/themes/custom/cruk/fonts/museo/MuseoSans-500.woff2" rel="preload" as="font" crossorigin="1">
<link href="/sites/all/themes/custom/cruk/fonts/progress/Progress-Regular.woff" rel="preload" as="font" crossorigin="1">
<link href="/sites/all/themes/custom/cruk/fonts/Poppins-Regular.woff2" rel="preload" as="font" crossorigin="1">
<link rel="alternate" href="https://www.cancerresearchuk.org/health-professional/treatment-and-other-post-diagnosis-issues/consent-forms-for-sact-systemic-anti-cancer-therapy" hreflang="en-gb">
<script>{
    "@context": "https://schema.org",
    "@graph": [
        {
            "@type": "Organization",
            "additionalType": "NGO",
            "@id": "https://www.cancerresearchuk.org",
            "name": "Cancer Research UK",
            "address": {
                "@type": "PostalAddress",
                "streetAddress": "2 Redman Place",
                "addressRegion": "London",
                "postalCode": "E20 1JQ",
                "addressCountry": "UK"
            },
            "telephone": "03001234452",
            "url": "https://www.cancerresearchuk.org/",
            "sameAs": [
                "https://en.wikipedia.org/wiki/Cancer_Research_UK",
                "https://www.youtube.com/cancerresearchuk",
                "https://en-gb.facebook.com/cancerresearchuk",
                "https://twitter.com/CR_UK",
                "https://www.instagram.com/cr_uk",
                "https://www.linkedin.com/company/cancer-research-uk"
            ],
            "image": {
                "@type": "ImageObject",
                "url": "https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/cruk-logo.svg"
            },
            "logo": {
                "@type": "ImageObject",
                "representativeOfPage": "True",
                "url": "https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/cruk-logo.svg"
            }
        }
    ]
}</script>
<meta name="description" content="Standardised SACT regimen-specific consent forms for Clinicians and healthcare professionals involved with consenting and treating patients with SACT.">
<link rel="canonical" href="https://www.cancerresearchuk.org/health-professional/treatment-and-other-post-diagnosis-issues/consent-forms-for-sact-systemic-anti-cancer-therapy">
<link rel="shortlink" href="https://www.cancerresearchuk.org/node/152106">
<meta property="og:site_name" content="Cancer Research UK">
<meta property="og:type" content="article">
<meta property="og:title" content="Consent forms for SACT (Systemic Anti-Cancer Therapy)">
<meta property="og:url" content="https://www.cancerresearchuk.org/health-professional/treatment-and-other-post-diagnosis-issues/consent-forms-for-sact-systemic-anti-cancer-therapy">
<meta property="og:description" content="Standardised SACT regimen-specific consent forms for Clinicians and healthcare professionals involved with consenting and treating patients with SACT.">
<meta property="og:updated_time" content="2025-07-01T10:13:17+01:00">
<meta property="og:image" content="https://www.cancerresearchuk.org/sites/default/files/health_professional_sact.png">
<meta name="twitter:card" content="summary">
<meta name="twitter:url" content="https://www.cancerresearchuk.org/health-professional/treatment-and-other-post-diagnosis-issues/consent-forms-for-sact-systemic-anti-cancer-therapy">
<meta name="twitter:title" content="Consent forms for SACT (Systemic Anti-Cancer Therapy)">
<meta name="twitter:description" content="Standardised SACT regimen-specific consent forms for Clinicians and healthcare professionals involved with consenting and treating patients with SACT.">
<meta property="article:published_time" content="2016-09-09T13:31:27+01:00">
<meta property="article:modified_time" content="2025-07-01T10:13:17+01:00">

      <link rel="apple-touch-icon" sizes="57x57" href="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/apple-touch-icon-57x57.png">
<link rel="apple-touch-icon" sizes="60x60" href="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/apple-touch-icon-60x60.png">
<link rel="apple-touch-icon" sizes="72x72" href="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/apple-touch-icon-72x72.png">
<link rel="apple-touch-icon" sizes="76x76" href="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/apple-touch-icon-76x76.png">
<link rel="apple-touch-icon" sizes="114x114" href="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/apple-touch-icon-114x114.png">
<link rel="apple-touch-icon" sizes="120x120" href="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/apple-touch-icon-120x120.png">
<link rel="apple-touch-icon" sizes="144x144" href="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/apple-touch-icon-144x144.png">
<link rel="apple-touch-icon" sizes="60x60" href="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/apple-touch-icon-152x152.png">
<link rel="apple-touch-icon" sizes="60x60" href="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/apple-touch-icon-180x180.png">
<link rel="icon" type="image/png" href="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/favicon-32x32.png" sizes="32x32">
<link rel="icon" type="image/png" href="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/favicon-194x194.png" sizes="194x194">
<link rel="icon" type="image/png" href="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/favicon-32x32.png" sizes="96x96">
<link rel="icon" type="image/png" href="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/android-chrome-192x192.png" sizes="192x192">
<meta name="theme-color" content="#ffffff">
<link rel="icon" type="image/png" href="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/favicon-16x16.png" sizes="16x16">
<link rel="manifest" href="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/manifest.json">
<link rel="shortcut icon" href="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/favicon.ico">
<meta name="msapplication-TileImage" content="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/mstile-144x144.png">
<meta name="msapplication-TileColor" content="#ec008c">
<meta name="msapplication-config" content="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/favicons/browserconfig.xml">
<meta name="apple-mobile-web-app-title" content="CRUK">
<meta name="application-name" content="CRUK">
  
  <meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1">
  <meta http-equiv="cleartype" content="on">
  <meta name="viewport" content="width=device-width, initial-scale=1">

  <style>
@import url("https://www.cancerresearchuk.org/modules/system/system.base.css?");
@import url("https://www.cancerresearchuk.org/modules/system/system.menus.css?");
@import url("https://www.cancerresearchuk.org/modules/system/system.messages.css?");
@import url("https://www.cancerresearchuk.org/modules/system/system.theme.css?");
</style>
<style>@font-face{font-family:"MuseoSansRounded-500";font-display:swap;src:url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSansRounded-500.eot");src:url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSansRounded-500.eot?#iefix") format("embedded-opentype"),url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSansRounded-500.woff2") format("woff2"),url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSansRounded-500.woff") format("woff"),url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSansRounded-500.ttf") format("truetype")}@font-face{font-family:"MuseoSansRounded-700";font-display:swap;src:url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSansRounded-700.eot");src:url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSansRounded-700.eot?#iefix") format("embedded-opentype"),url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSansRounded-700.woff2") format("woff2"),url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSansRounded-700.woff") format("woff"),url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSansRounded-700.ttf") format("truetype")}@font-face{font-family:"MuseoSans-500";font-display:swap;src:url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSans-500.eot");src:url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSans-500.eot?#iefix") format("embedded-opentype"),url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSans-500.woff2") format("woff2"),url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSans-500.woff") format("woff"),url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSans-500.ttf") format("truetype")}@font-face{font-family:"MuseoSans-700";font-display:swap;src:url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSans-700.eot");src:url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSans-700.eot?#iefix") format("embedded-opentype"),url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSans-700.woff2") format("woff2"),url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSans-700.woff") format("woff"),url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSans-700.ttf") format("truetype")}@font-face{font-family:"Progress";font-display:swap;src:url("/sites/all/themes/custom/cruk/fonts/progress/Progress-Regular.woff")}@font-face{font-family:'CRUKIcons';src:url("/sites/all/themes/custom/cruk/fonts/cruk-icons/CRUKIcons.eot");src:url("/sites/all/themes/custom/cruk/fonts/cruk-icons/CRUKIcons.eot#iefix") format("embedded-opentype"),url("/sites/all/themes/custom/cruk/fonts/cruk-icons/CRUKIcons.woff") format("woff"),url("/sites/all/themes/custom/cruk/fonts/cruk-icons/CRUKIcons.ttf") format("truetype"),url("/sites/all/themes/custom/cruk/fonts/cruk-icons/CRUKIcons.svg#CRUKIcons") format("svg");font-weight:normal;font-style:normal}.cr-i{display:inline-block;font:normal normal normal 14px/1 CRUKIcons;font-size:inherit;text-rendering:auto;-webkit-font-smoothing:antialiased;-moz-osx-font-smoothing:grayscale;speak:none}.cr-i--chevron-down:before{content:"\e905"}body{font-family:"Arial",sans-serif;font-size:14px;padding:0}.container{max-width:960px}*,*:before,*:after{-moz-box-sizing:border-box;-webkit-box-sizing:border-box;box-sizing:border-box}.inner{width:auto;margin:0}@media screen and (min-width: 981px){.inner{width:940px;margin:0 auto}}@media screen and (max-width: 480px){.wrapper{overflow:visible}}@media screen and (min-width: 981px){.wrapper{overflow:hidden;padding-top:0}}/*! normalize.css v2.1.3 | MIT License | git.io/normalize */article,aside,details,figcaption,figure,footer,header,hgroup,main,nav,section,summary{display:block}audio,canvas,video{display:inline-block}audio:not([controls]){display:none;height:0}[hidden],template{display:none}html{font-family:sans-serif;-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%}body{margin:0}a{background:transparent}a:focus{outline:thin dotted}a:active,a:hover{outline:0}h1{font-size:2em;margin:0.67em 0}abbr[title]{border-bottom:1px dotted}b,strong{font-weight:bold}dfn{font-style:italic}hr{-moz-box-sizing:content-box;box-sizing:content-box;height:0}mark{background:#ff0;color:#000}code,kbd,pre,samp{font-family:monospace, serif;font-size:1em}pre{white-space:pre-wrap}q{quotes:"\201C" "\201D" "\2018" "\2019"}small{font-size:80%}sub,sup{font-size:75%;line-height:0;position:relative;vertical-align:baseline}sup{top:-0.5em}sub{bottom:-0.25em}img{border:0}svg:not(:root){overflow:hidden}figure{margin:0}fieldset{border:1px solid #c0c0c0;margin:0 2px;padding:0.35em 0.625em 0.75em}legend{border:0;padding:0}button,input,select,textarea{font-family:inherit;font-size:100%;margin:0}button,input{line-height:normal}button,select{text-transform:none}button,html input[type="button"],input[type="reset"],input[type="submit"]{-webkit-appearance:button;cursor:pointer}button[disabled],html input[disabled]{cursor:default}input[type="checkbox"],input[type="radio"]{box-sizing:border-box;padding:0}input[type="search"]{-webkit-appearance:textfield;-moz-box-sizing:content-box;-webkit-box-sizing:content-box;box-sizing:content-box}input[type="search"]::-webkit-search-cancel-button,input[type="search"]::-webkit-search-decoration{-webkit-appearance:none}button::-moz-focus-inner,input::-moz-focus-inner{border:0;padding:0}textarea{overflow:auto;vertical-align:top}table{border-collapse:collapse;border-spacing:0}.container{width:auto;margin-left:auto;margin-right:auto}html{line-height:1.5}body{background-color:#f5f5f5;color:#333}h1{font-size:28px;line-height:1em}@media screen and (max-width: 640px){h1{font-size:23.996px;line-height:1.08em}}h2{font-size:21px;line-height:1.1em}main>h1{clear:both;margin-top:0;padding:15px 0 20px 10px}h1,h2{margin:0 0 .5em;color:#333}h2 a:link{text-decoration:none}p{margin:0 0 1em}header{overflow:hidden}input,button{white-space:normal}a:link{color:#2E008B}.more{margin-bottom:0;list-style:none}.more a{background:transparent url("/sites/all/themes/custom/cruk/images/pink-arrow.png") no-repeat 0 center;color:#e40085;text-decoration:none;padding-left:15px;font-weight:bold}input[type="submit"]{padding:11px 20px;font-family:"MuseoSansRounded-700","MuseoSans-700","Arial","Helvetica",sans-serif;font-size:16.002px;line-height:1.125em;text-align:center;color:#fff;background-color:#e40085;border:none;-moz-border-radius:3px;-webkit-border-radius:3px;border-radius:3px}.button{text-align:center;margin:.5em auto;display:inline-block}.secondary-button a {padding: 11px 10px;text-decoration: none !important;font-family: "MuseoSansRounded-700","MuseoSans-700","Arial","Helvetica",sans-serif;font-size: 16px;line-height: 21px;text-align: center;color: #e40085;background-color: #ffffff;border: 1px solid #e40085;border-radius: 3px}.button a{padding:11px 20px;text-decoration:none !important;display:block;font-family:"MuseoSansRounded-700","MuseoSans-700","Arial","Helvetica",sans-serif;font-size:16.002px;line-height:1.125em;text-align:center;color:#fff;background-color:#e40085;border:none;-moz-border-radius:3px;-webkit-border-radius:3px;border-radius:3px}.site-slogan{color:#2E008B}.lazyloader-icon{position:absolute;z-index:200}.lazyloader-icon{border:3px solid #E4E4E4;border-radius:50%;border-top:3px solid #00b6ed;width:20px;height:20px;-webkit-animation:spin 2s linear infinite;animation:spin 2s linear infinite;display:block;position:absolute;top:50%;left:50%;margin-left:-10px;margin-top:-10px}.siteinfo{background-color:#fff;display:flex;align-items:center;justify-content:space-between;padding-top:0}.siteinfo a{text-decoration:none}a.mhead-right{text-decoration:none}a.mhead-right:link,a.mhead-right:visited{padding:11px 20px;background-color:#e40085;-moz-border-radius:3px;-webkit-border-radius:3px;border-radius:3px;text-align:center;color:#fff;font-size:16.002px;line-height:1.125em;font-family:"MuseoSansRounded-700","MuseoSans-700","Arial","Helvetica",sans-serif}a.mhead-right:focus,a.mhead-right:hover,a.mhead-right:active{background-color:#F033A3}.site-slogan{font-size:1.7em;line-height:1.4em;font-family:"Progress","Arial","Helvetica",sans-serif;margin-bottom:0;color:#000}.site-slogan>a:hover,.site-slogan>a:visited{text-decoration:none;color:#2E008B}.page-node-64706 .siteinfo .mhead-right{display:none}#breadcrumb{background-color:#f5f5f5}#breadcrumb .breadcrumb{font-size:.833em;display:inline;color:#333}@media screen and (max-width: 480px){#breadcrumb{padding:9px 10px 0}}@media screen and (min-width: 481px) and (max-width: 640px){#breadcrumb{padding:9px 20px 0}}@media screen and (min-width: 641px) and (max-width: 800px){#breadcrumb{padding:9px 45px 0}}@media screen and (min-width: 801px) and (max-width: 980px){#breadcrumb{padding:11px 20px 0}}@media screen and (min-width: 981px){#breadcrumb{padding:13px 20px 0}}.in-maintenance .siteinfo{padding-bottom:10px}.in-maintenance #footer-txt{display:none}#dd-searchform{display:flex}#dd-searchform>input{box-sizing:border-box}#cruk-search{font-size:16px;padding:0 0 0 5px}#cruk-search .search{height:40px;width:145px;-moz-border-radius:4px;-webkit-border-radius:4px;border-radius:4px;border:2px solid #C8C8C8;border-right-width:0;border-top-right-radius:0;border-bottom-right-radius:0;padding:1px 0 0 1em}#cruk-search .search::placeholder{color:#C8C8C8}#cruk-search .searchsubmit{border:2px solid #C8C8C8;-moz-border-radius:4px;-webkit-border-radius:4px;border-radius:4px;border-bottom-left-radius:0;border-top-left-radius:0;border-left-width:0;background-color:#fff;color:#C8C8C8}#cruk-search .search:focus{border-color:#00B6ED;outline-width:0}#cruk-search .search:focus+.searchsubmit{border-color:#00B6ED;color:#2E008B}header{background-color:#fff}.header-region{border-top:1px solid #e3e3e3;border-bottom:1px solid #e3e3e3;background-color:#fafafa}.header-region nav{display:none}.megamenu{display:flex;justify-content:space-between;align-items:center;border:none;padding:0;margin:0;font-family:"MuseoSansRounded-500","MuseoSans-500","Arial","Helvetica",sans-serif;font-weight:500;list-style:none}.megamenu p{margin:0}.megamenu .clear-fix{float:none;clear:both;margin:0;padding:0;height:0;font-size:0;line-height:0}.megamenu>li>div{display:none}.mm-item>p{display:flex;height:60px}.mm-item-link:link,.mm-item-link:visited{color:#2E008B;font-family:"MuseoSansRounded-500","MuseoSans-500","Arial","Helvetica",sans-serif;font-weight:500;font-size:17px;text-decoration:none;padding:0 5px;line-height:20px;z-index:10;display:flex;align-items:center;border-left:1px solid transparent}.mm-item-link:link+.cr-i,.mm-item-link:visited+.cr-i{color:#A7A8AA;display:flex;align-items:center;border-right:1px solid transparent;padding-right:5px}.mm-item-link:last-child{border-right:1px solid transparent}.mm-item-link-hover:link,.mm-item-link-hover:visited{color:#e40085;padding-right:5px;border-color:#e3e3e3;z-index:1001}.mm-item-link-hover:link+.cr-i,.mm-item-link-hover:visited+.cr-i{color:#e40085;border-color:#e3e3e3}.mm-item.selected p>.mm-item-link.mm-item-link,.mm-item.selected p>.cr-i--chevron-down{color:#e40085}.mm-item-content{background-color:#fafafa;border:1px solid #e3e3e3;height:auto;margin-top:1px;position:absolute;z-index:101}.list-content,.list-content ul{padding:0;list-style:none}.toplevel{color:#2E008B;padding:12px 0 5px 20px;width:187px;float:left}.toplevel>p{font-size:14px;line-height:17px}.toplevel>p a{text-decoration:none;color:#2E008B}.toplevel>ul{height:auto;padding:10px 0 0}.toplevel li{margin-bottom:10px}.level3:link,.level3:visited{color:#333;text-decoration:none;font-size:14px;font-weight:normal;line-height:18px;padding-top:0}.level3:hover{color:#e40085}.cruk-logo img{width:100%;height:auto;display:block}#masthead_table{display:none !important}#mobile-rebrand-wrapper{display:block}@media screen and (min-width: 980px){#masthead_table{display:block !important}#mobile-rebrand-wrapper{margin:0 -16px;display:none}}.skip-link{width:100%}.skip-link .element-focusable:focus{position:absolute !important}#main-content:focus{outline:none !important}#mobile-navbar-container{background-color:#FAFAFA}#mobile-rebrand-wrapper #mobile-navbar-container>ul{margin-top:0;display:flex;justify-content:flex-start;height:50px;border-bottom:1px solid #e3e3e3}#mobile-rebrand-wrapper #mobile-navbar-container>ul li{display:flex;align-items:center}@media screen and (max-width: 800px){#top-page,#cruk-search,.site-slogan{display:none}.cruk-logo{padding-left:45px}.mhead-right{margin-right:45px}.siteinfo{padding-top:17px;padding-bottom:17px}}@media screen and (min-width: 481px) and (max-width: 800px){.site-slogan{display:none}}@media screen and (max-width: 480px){.cruk-logo{flex-basis:40%;padding-left:17px}.mhead-right{margin-right:15px}}@media screen and (min-width: 481px) and (max-width: 640px){.cruk-logo{padding-left:20px;width:140px}.mhead-right{margin-right:20px}}@media screen and (min-width: 800px) and (max-width: 980px){.cruk-logo{margin-left:20px}#cruk-nav{padding-left:20px}.mhead-right{margin-right:20px}#cruk-search{display:none}}@media screen and (min-width: 800px){.siteinfo{margin-top:30px;margin-bottom:17px}}.panel-related-row:before,.panel-related-row:after{content:" ";display:table}.panel-related-row:after{clear:both}.pane-promo,.feed-list,.pane-img-text,.pane-bundle-two-column-multi-alignment{background-color:#fff}.grey-panel{background-color:#e3e3e3}.blue-panel img,.white-panel img,.grey-panel img,.pane-show-hide img,.feed-list img,.pane-promo img,.pane-img-text img,.pane-bundle-two-column-multi-alignment img{width:100%;height:auto}.pane-bundle-donation-pane{display:none;background-repeat:no-repeat;background-size:cover;background-position:center}.pane-bundle-donation-pane.visible{display:block}.pane-bundle-donation-pane fieldset{padding:0;margin:0;border:0}.pane-bundle-donation-pane:after{display:none}.pane-bundle-donation-pane .pane-content{color:#fff;height:320px;margin-bottom:20px;text-align:center}.pane-bundle-donation-pane .pane-content:before{content:"";display:inline-block;height:100%;vertical-align:middle;margin-right:-0.25em}.pane-bundle-donation-pane .pane-content form{height:100%;display:block;padding:1em;position:relative}.pane-bundle-donation-pane .pane-content form>div{height:100%}.pane-bundle-donation-pane .pane-content h2{color:#fff;font-size:1.86em;line-height:1.1em;margin-bottom:.2em;margin-left:auto;margin-right:auto;max-width:260px}@media screen and (min-width: 800px){.pane-bundle-donation-pane .pane-content h2{line-height:1.4em;margin-bottom:.35em;max-width:600px}}.pane-bundle-donation-pane .pane-content .form-radios label{display:inline}.homepage .pane-bundle-donation-pane{background-repeat:no-repeat;border-radius:0;background-color:#2E008B}.homepage .pane-bundle-donation-pane .pane-content:before{display:none}.homepage .pane-bundle-donation-pane .pane-content form{height:100%;display:block;padding:1em;position:relative}@media screen and (min-width: 641px){.homepage .pane-bundle-donation-pane .pane-content form{float:right}}@media screen and (min-width: 801px){.homepage .pane-bundle-donation-pane .pane-content form{width:38%}}.homepage .pane-bundle-donation-pane .pane-content form>div{height:100%}.homepage .pane-bundle-donation-pane .pane-content form>div:before{content:"";display:inline-block;height:100%;vertical-align:middle;margin-right:-0.25em}.homepage .pane-bundle-donation-pane .form-steps{display:inline-block;vertical-align:bottom;margin-bottom:.5em}@media screen and (min-width: 641px){.homepage .pane-bundle-donation-pane .form-steps{vertical-align:middle}}.direct-donation-v2-pane.pane-bundle-donation-pane{display:block;background-position:30%}@media screen and (min-width: 800px){.direct-donation-v2-pane.pane-bundle-donation-pane{background-position:left}}@media screen and (min-width: 640px){.direct-donation-v2-pane.pane-bundle-donation-pane{background-position:15%}}.direct_donation_v2#cruk-donate-donation-pane-form .branding-content{height:100%;width:100%;padding:1em;display:table}@media screen and (min-width: 640px){.direct_donation_v2#cruk-donate-donation-pane-form .branding-content{padding-bottom:1em;width:63%}}.direct_donation_v2#cruk-donate-donation-pane-form .branding-content .branding-content-inner{display:table-cell;padding-bottom:0;vertical-align:bottom}@media screen and (min-width: 640px){.direct_donation_v2#cruk-donate-donation-pane-form .branding-content .branding-content-inner{padding:0 25% 0 0}}.direct_donation_v2#cruk-donate-donation-pane-form .donate-panel-heading{font-size:22px;line-height:normal;text-shadow:0 0 20px rgba(0,0,0,0.75);width:100%;padding:0 0 .5em;margin-bottom:0;max-width:100%;text-align:center;letter-spacing:.03em}@media screen and (min-width: 640px){.direct_donation_v2#cruk-donate-donation-pane-form .donate-panel-heading{font-size:26px;line-height:28px;text-align:left;padding:0 0 7% 5%}}.direct_donation_v2#cruk-donate-donation-pane-form .donate-panel-subheading{display:none}.direct_donation_v2#cruk-donate-donation-pane-form .direct-donation-v2-form{background-color:#fff;border-radius:0;z-index:1;display:block;margin-bottom:20px;padding:2em;position:relative;float:left;width:100%;box-sizing:border-box}@media screen and (min-width: 640px){.direct_donation_v2#cruk-donate-donation-pane-form .direct-donation-v2-form{float:none;padding:1em;position:absolute;top:3em;right:6em;max-width:calc(28% - 2em);margin-bottom:0}}@media screen and (max-width: 800px) and (min-width: 640px){.direct_donation_v2#cruk-donate-donation-pane-form .direct-donation-v2-form{top:2em;right:2em;max-width:calc(33% - 2em)}}@media screen and (min-width: 640px){.homepage .direct_donation_v2#cruk-donate-donation-pane-form .branding-content{padding-bottom:1em;width:67%}}.homepage .direct_donation_v2#cruk-donate-donation-pane-form .donate-panel-heading{padding:0 0 .5em;margin-bottom:0}@media screen and (min-width: 640px){.homepage .direct_donation_v2#cruk-donate-donation-pane-form .donate-panel-heading{font-size:26px;line-height:40px;text-align:left;padding:0 0 0 20%}}.homepage .direct_donation_v2#cruk-donate-donation-pane-form .donate-panel-subheading{display:block;font-size:16px}@media screen and (min-width: 640px){.homepage .direct_donation_v2#cruk-donate-donation-pane-form .donate-panel-subheading{font-size:18px;text-align:left;margin-left:20%}}.homepage .direct_donation_v2#cruk-donate-donation-pane-form .direct-donation-v2-form{margin-bottom:0}@media screen and (min-width: 640px){.homepage .direct_donation_v2#cruk-donate-donation-pane-form .direct-donation-v2-form{right:2em;top:2em}}@media screen and (max-width: 640px){.direct-donation-v2-pane.pane-bundle-donation-pane .pane-content:before{display:none}}.direct_donation_v2#cruk-donate-donation-pane-form{padding:0;width:100%;font-family:"MuseoSansRounded-500","MuseoSans-500","Arial","Helvetica",sans-serif;display:block}@media screen and (min-width: 640px){.direct_donation_v2#cruk-donate-donation-pane-form{float:right}}.direct_donation_v2#cruk-donate-donation-pane-form>div:before{display:none}.direct_donation_v2#cruk-donate-donation-pane-form #edit-donation-type input[name="donation_type"]{position:fixed;opacity:0}.direct_donation_v2#cruk-donate-donation-pane-form #edit-donation-type div{width:47%;display:inline-block;font-size:20px}@media screen and (min-width: 640px){.direct_donation_v2#cruk-donate-donation-pane-form #edit-donation-type div{font-size:14px}}.direct_donation_v2#cruk-donate-donation-pane-form #edit-donation-type label{background-color:#fff;border:1px solid #2E008B;color:#2E008B;display:block;font-weight:normal;padding:12px}@media screen and (min-width: 640px){.direct_donation_v2#cruk-donate-donation-pane-form #edit-donation-type label{padding:8px}}.direct_donation_v2#cruk-donate-donation-pane-form #edit-donation-type label:hover,.direct_donation_v2#cruk-donate-donation-pane-form #edit-donation-type label:focus{background-color:#2E008B !important;color:#fff;cursor:pointer}.direct_donation_v2#cruk-donate-donation-pane-form #edit-donation-type input[name="donation_type"]:checked+label{color:#fff;background-color:#2E008B}.direct_donation_v2#cruk-donate-donation-pane-form #edit-donation-type{display:flex;justify-content:space-between}.direct_donation_v2#cruk-donate-donation-pane-form #edit-monthly div,.direct_donation_v2#cruk-donate-donation-pane-form #edit-single div{display:flex;font-family:"MuseoSansRounded-500","MuseoSans-500","Arial","Helvetica",sans-serif;width:100%;color:#2E008B;background-color:#fff;margin-right:5%}.direct_donation_v2#cruk-donate-donation-pane-form #edit-monthly div div:last-child,.direct_donation_v2#cruk-donate-donation-pane-form #edit-single div div:last-child{margin-right:0px}.direct_donation_v2#cruk-donate-donation-pane-form #edit-monthly div input,.direct_donation_v2#cruk-donate-donation-pane-form #edit-single div input{position:fixed;opacity:0}.direct_donation_v2#cruk-donate-donation-pane-form #edit-monthly div div,.direct_donation_v2#cruk-donate-donation-pane-form #edit-single div div{width:47%;display:inline-block;font-size:20px}@media screen and (min-width: 640px){.direct_donation_v2#cruk-donate-donation-pane-form #edit-monthly div div,.direct_donation_v2#cruk-donate-donation-pane-form #edit-single div div{font-size:14px}}@media screen and (max-width: 638px){.direct_donation_v2#cruk-donate-donation-pane-form #edit-monthly div div,.direct_donation_v2#cruk-donate-donation-pane-form #edit-single div div{padding-top:30px;display:inline-block}}.direct_donation_v2#cruk-donate-donation-pane-form #edit-monthly div label,.direct_donation_v2#cruk-donate-donation-pane-form #edit-single div label{background-color:#fff;border:2px solid #e3e3e3;color:#2E008B;display:block;font-weight:normal;padding:12px}@media screen and (min-width: 640px){.direct_donation_v2#cruk-donate-donation-pane-form #edit-monthly div label,.direct_donation_v2#cruk-donate-donation-pane-form #edit-single div label{padding:4px 0px 4px 0px}}.direct_donation_v2#cruk-donate-donation-pane-form #edit-monthly div label:hover,.direct_donation_v2#cruk-donate-donation-pane-form #edit-monthly div label:focus,.direct_donation_v2#cruk-donate-donation-pane-form #edit-single div label:hover,.direct_donation_v2#cruk-donate-donation-pane-form #edit-single div label:focus{background-color:#2E008B !important;color:#fff;cursor:pointer}.direct_donation_v2#cruk-donate-donation-pane-form #edit-monthly div input:checked+label,.direct_donation_v2#cruk-donate-donation-pane-form #edit-single div input:checked+label{color:#fff;background-color:#2E008B}@media screen and (min-width: 640px){.direct_donation_v2#cruk-donate-donation-pane-form #edit-monthly div,.direct_donation_v2#cruk-donate-donation-pane-form #edit-single div{padding:9px 0;font-size:inherit}}.direct_donation_v2#cruk-donate-donation-pane-form #edit-single>div,.direct_donation_v2#cruk-donate-donation-pane-form #edit-monthly>div{border:none}@media screen and (min-width: 640px){.direct_donation_v2#cruk-donate-donation-pane-form #edit-single>div,.direct_donation_v2#cruk-donate-donation-pane-form #edit-monthly>div{padding:9px 0;font-size:inherit}}.direct_donation_v2#cruk-donate-donation-pane-form .amount-separator{font-family:"MuseoSansRounded-500","MuseoSans-500","Arial","Helvetica",sans-serif;font-size:20px;margin-bottom:5%;color:#2E008B}@media screen and (min-width: 640px){.direct_donation_v2#cruk-donate-donation-pane-form .amount-separator{font-size:16px}}@media screen and (max-width: 638px){.direct_donation_v2#cruk-donate-donation-pane-form .amount-separator{padding-top:15px}}.direct_donation_v2#cruk-donate-donation-pane-form .pound-symbol{position:absolute;font-size:20px;margin:13px 0 0 12px;color:#2E008B;font-family:"MuseoSansRounded-500","MuseoSans-500","Arial","Helvetica",sans-serif}@media screen and (min-width: 640px){.direct_donation_v2#cruk-donate-donation-pane-form .pound-symbol{font-size:18px;margin:8px 0 0 12px}}.direct_donation_v2#cruk-donate-donation-pane-form #edit-amount-other{width:100%;padding:14px 10px 14px 35px;font-size:20px;color:#2E008B;font-family:"MuseoSansRounded-500","MuseoSans-500","Arial","Helvetica",sans-serif;border:2px solid #e3e3e3}@media screen and (min-width: 640px){.direct_donation_v2#cruk-donate-donation-pane-form #edit-amount-other{padding:10px 10px 10px 35px;font-size:15px}}.direct_donation_v2#cruk-donate-donation-pane-form #edit-amount-other:focus{border-color:#e40085;outline:0}.direct_donation_v2#cruk-donate-donation-pane-form #edit-amount-other::placeholder{font-size:20px;color:#C8C9C7;font-family:"MuseoSansRounded-500","MuseoSans-500","Arial","Helvetica",sans-serif}@media screen and (min-width: 640px){.direct_donation_v2#cruk-donate-donation-pane-form #edit-amount-other::placeholder{font-size:15px}}.direct_donation_v2#cruk-donate-donation-pane-form .input-other-amnt-wrapper{float:none;display:block;position:relative}.direct_donation_v2#cruk-donate-donation-pane-form .submit-btn{width:100%;height:50px;font-family:"MuseoSansRounded-500","MuseoSans-500","Arial","Helvetica",sans-serif;font-size:20px;color:#fff;background:#e40085;margin:10% 0 0 0;padding:0}.direct_donation_v2#cruk-donate-donation-pane-form .submit-btn:hover{background:#F033A3}@media screen and (min-width: 640px){.direct_donation_v2#cruk-donate-donation-pane-form .submit-btn{font-size:16px;height:42px}}fieldset{-moz-border-radius:3px;-webkit-border-radius:3px;border-radius:3px;border:1px solid #e3e3e3;background-color:#fff;margin:0 0 20px 0;padding:15px 20px 20px;clear:both}
/*# sourceMappingURL=critical.css.map */
</style>
<style>
@import url("https://www.cancerresearchuk.org/sites/all/modules/contrib/jquery_update/replace/ui/themes/base/minified/jquery.ui.core.min.css?");
@import url("https://www.cancerresearchuk.org/sites/all/modules/contrib/jquery_update/replace/ui/themes/base/minified/jquery.ui.theme.min.css?");
</style>
<style>
@import url("https://www.cancerresearchuk.org/modules/aggregator/aggregator.css?");
@import url("https://www.cancerresearchuk.org/sites/all/modules/custom/cruk_gc_timeline/css/grand_challenge_timeline.css?");
@import url("https://www.cancerresearchuk.org/modules/field/theme/field.css?");
@import url("https://www.cancerresearchuk.org/sites/all/modules/contrib/geofield_gmap/geofield_gmap.css?");
@import url("https://www.cancerresearchuk.org/modules/node/node.css?");
@import url("https://www.cancerresearchuk.org/modules/search/search.css?");
@import url("https://www.cancerresearchuk.org/modules/user/user.css?");
@import url("https://www.cancerresearchuk.org/sites/all/modules/contrib/extlink/css/extlink.css?");
@import url("https://www.cancerresearchuk.org/sites/all/modules/contrib/views/css/views.css?");
@import url("https://www.cancerresearchuk.org/sites/all/modules/contrib/ckeditor/css/ckeditor.css?");
</style>
<style>
@import url("https://www.cancerresearchuk.org/sites/all/modules/contrib/ctools/css/ctools.css?");
@import url("https://www.cancerresearchuk.org/sites/all/modules/contrib/panels/css/panels.css?");
@import url("https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/layouts/landing_page_kids_and_teens/landing_page_kids_and_teens.css?");
@import url("https://www.cancerresearchuk.org/sites/all/modules/custom/cruk_donate/selectmenu/jquery.ui.selectmenu.css?");
@import url("https://www.cancerresearchuk.org/sites/all/modules/contrib/node_embed/plugins/node_embed/node_embed.css?");
@import url("https://www.cancerresearchuk.org/sites/all/modules/custom/cruk_taxonomy_glossary/css/cruk_taxonomy_glossary.css?");
</style>
<style>
@import url("https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/css/tabs_to_accordion.css?");
@import url("https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/css/style.css?");
@import url("https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/css/cruk.menus.css?");
@import url("https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/css/mobile.menu.css?");
@import url("https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/css/slick.css?");
</style>
<style media="print">
@import url("https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/css/print.css?");
</style>
<style>
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_31.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_131.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_156.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_196.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_201.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_206.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_211.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_226.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_241.css?");
</style>
<link rel="stylesheet" href="https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_251.css?" media="screen">
<style>
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_261.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_276.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_281.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_291.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_296.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_306.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_361.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_371.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_376.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_426.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_441.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_456.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_466.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_471.css?");
</style>
<style media="screen">
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_516.css?");
</style>
<link rel="stylesheet" href="https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_561.css?">
<style>
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_576.css?");
</style>
<link rel="stylesheet" href="https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_581.css?">
<link rel="stylesheet" href="https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_610.css?">
<style>
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_616.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_617.css?");
</style>
<link rel="stylesheet" href="https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_619.css?">
<style>
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_620.css?");
</style>
  <script>
    window.CancerResearchUK = {};
  </script>
    <!--[if lt IE 9]>
  <script src="https://www.cancerresearchuk.org/sites/all/themes/contrib/mothership/mothership/js/respond.min.js"></script>
  <script src="https://www.cancerresearchuk.org/sites/all/themes/contrib/mothership/mothership/js/html5.js"></script>
  <![endif]-->

  </head>

<body class="not-front no-sidebars page-node page-node- page-node-152106 node-type-cancer-information-standard-page">

<!-- The gtm id code variable ($gtm_code) is set in gtm-header.inc.php -->

  <!-- Google Tag Manager (noscript) -->
  <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-W3ZV" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
  <!-- End Google Tag Manager (noscript) -->

<div id="top-page">
  <div class="inner">
    <div class="skip-link"><a href="#main-content" class="element-invisible element-focusable">Skip to main content</a></div>
  </div>
</div>


<header role="banner">
  <div class="siteinfo inner">
          <div class="cruk-logo">
        <a href="/" title="Cancer Research UK Homepage" rel="home">
          <img src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk_integrated_campaign/logo.svg" width="222" height="86" alt="Cancer Research UK Homepage">
        </a>
      </div>
    
          <p class="site-slogan">Together we are beating cancer</p>
    
    
    <div id="cruk-search">
      <form action="https://find.cancerresearchuk.org/" id="dd-searchform">
        <input type="hidden" value="1" name="siteid">
        <input type="text" class="search" placeholder="Search" name="q" id="q">
        <button aria-label="Search" name="searchsubmit" id="searchsubmit" class="searchsubmit">
          <span class="cr-i cr-i--search"></span>
        </button>
      </form>
    </div>



    <a class="mhead-right" href="/get-involved/donate/">Donate</a>
  </div><!-- #siteinfo -->

  <div class="header-region">
    <div class="inner">
            <!-- start: ul megamenu -->
      <div>
    <div id="cruk-nav">
      <div id="masthead_table">
        <ul class="megamenu" id="drupal-mdd"><li class="mm-item"><p><a href="/about-cancer/" class="mm-item-link">About cancer</a><span class="cr-i cr-i--chevron-down"></span></p>
      <div style="width: 940px">
          <ul class="list-content" id="about-cancer-menu"><li class="toplevel"><p><a href="/about-cancer/type" class="level2">Cancer types</a></p><ul><li><a href="/about-cancer/breast-cancer" class="level3">Breast cancer</a></li><li><a href="/about-cancer/bowel-cancer" class="level3">Bowel cancer</a></li><li><a href="/about-cancer/lung-cancer" class="level3">Lung cancer</a></li><li><a href="/about-cancer/prostate-cancer" class="level3">Prostate cancer</a></li></ul></li><li class="toplevel"><p><a href="/about-cancer/cancer-in-general" class="level2">Cancers in general</a></p><ul><li><a href="/about-cancer/cancer-symptoms" class="level3">Symptoms</a></li><li><a href="/about-cancer/screening" class="level3">Screening</a></li><li><a href="/about-cancer/tests-and-scans" class="level3">Tests</a></li><li><a href="/about-cancer/treatment" class="level3">Treatment</a></li><li><a href="/about-cancer/find-a-clinical-trial" class="level3">Clinical trials</a></li></ul></li><li class="toplevel"><p><a href="/about-cancer/causes-of-cancer" class="level2">Causes of cancer</a></p><ul><li><a href="/about-cancer/causes-of-cancer/smoking-and-cancer" class="level3">Smoking</a></li><li><a href="/about-cancer/causes-of-cancer/alcohol-and-cancer" class="level3">Alcohol</a></li><li><a href="/about-cancer/causes-of-cancer/diet-and-cancer" class="level3">Diet</a></li><li><a href="/about-cancer/causes-of-cancer/bodyweight-and-cancer" class="level3">Obesity</a></li><li><a href="/about-cancer/causes-of-cancer/sun-uv-and-cancer" class="level3">Sun and UV</a></li></ul></li><li class="toplevel"><p><a href="/about-cancer/coping-with-cancer" class="level2">Coping with cancer</a></p><ul><li><a href="/about-cancer/coping-with-cancer/coping-physically/" class="level3">Managing symptoms and side effects</a></li><li><a href="/about-cancer/coping/mental-health-cancer" class="level3">Mental health and cancer</a></li><li><a href="/about-cancer/coping-with-cancer/coping-practically/" class="level3">Money and travel</a></li><li><a href="/about-cancer/coping-with-cancer/dying/" class="level3">Death and dying</a></li><li><a href="https://cancerchat.cancerresearchuk.org/" class="level3">Cancer Chat forum</a></li></ul></li><li class="toplevel"><p><a href="/health-professional" class="level2">Health Professionals</a></p><ul><li><a href="/health-professional/cancer-statistics" class="level3">Cancer Statistics</a></li><li><a href="/health-professional/screening" class="level3">Cancer Screening</a></li><li><a href="/health-professional/learning-and-support" class="level3">Learning and Support</a></li><li><a href="/health-professional/learning-and-development-tools/nice-cancer-referral-guidelines" class="level3">NICE suspected cancer referral guidelines</a></li></ul></li></ul>
      </div>
    </li><li class="mm-item"><p><a href="/get-involved" class="mm-item-link">Get involved</a><span class="cr-i cr-i--chevron-down"></span></p>
      <div style="width: 940px">
          <ul class="list-content" id="get-involved-menu"><li class="toplevel"><p><a href="/get-involved/donate" class="level2">Donate</a></p><ul><li><a href="/get-involved/donate" class="level3">Make a donation</a></li><li><a href="/get-involved/leave-a-legacy-gift-in-your-will" class="level3">Leave a legacy gift</a></li><li><a href="/get-involved/donate/donate-in-memory" class="level3">Donate in memory</a></li><li><a href="/get-involved/donate/philanthropy" class="level3">Philanthropy</a></li><li><a href="/node/143661" class="level3">Weekly Lottery</a></li></ul></li><li class="toplevel"><p><a href="/get-involved/find-an-event" class="level2">Find an event</a></p><ul><li><a href="https://raceforlife.cancerresearchuk.org/" class="level3">Race for Life</a></li><li><a href="/get-involved/find-an-event/charity-runs" class="level3">Charity runs</a></li><li><a href="/get-involved/find-an-event/charity-walks-treks-and-hikes" class="level3">Charity walks</a></li><li><a href="https://find.cancerresearchuk.org/events?size=n_20_n&amp;sort-field=startDate&amp;sort-direction=asc" class="level3">Search events</a></li><li><a href="http://relay.cancerresearchuk.org" class="level3">Relay For Life</a></li></ul></li><li class="toplevel"><p><a href="/get-involved/volunteer" class="level2">Volunteer</a></p><ul><li><a href="/get-involved/volunteer/volunteer-in-our-shops" class="level3">Volunteer in our shops</a></li><li><a href="/get-involved/volunteer/help-at-an-event" class="level3">Help at an event</a></li><li><a href="/get-involved/volunteer/help-us-raise-money" class="level3">Help us raise money</a></li><li><a href="/how-to-cancer-campaign" class="level3">Campaign for us</a></li></ul></li><li class="toplevel"><p><a href="/get-involved/do-your-own-fundraising" class="level2">Do your own fundraising</a></p><ul><li><a href="/get-involved/do-your-own-fundraising/fundraising-ideas" class="level3">Fundraising ideas</a></li><li><a href="/get-involved/do-your-own-fundraising/get-fundraising-pack" class="level3">Get a fundraising pack</a></li><li><a href="/get-involved/do-your-own-fundraising/return-your-money" class="level3">Return fundraising money</a></li><li><a href="/get-involved/do-your-own-fundraising/target-your-fundraising" class="level3">Fundraise by cancer type</a></li><li><a href="/get-involved/do-your-own-fundraising/practical-fundraising-help/set-up-a-cancer-research-uk-giving-page" class="level3">Set up a Cancer Research UK Giving Page</a></li></ul></li><li class="toplevel"><p>More...</p><ul><li><a href="/get-involved/find-a-shop" class="level3">Find a shop or superstore</a></li><li><a href="/get-involved/become-a-partner" class="level3">Become a partner</a></li><li><a href="/get-involved/donate/kids-and-teens" class="level3">Cancer Research UK for Children &amp; Young People</a></li><li><a href="/get-involved/we-are" class="level3">Our We Are campaign</a></li></ul></li></ul>
      </div>
    </li><li class="mm-item"><p><a href="/our-research" class="mm-item-link">Our research</a><span class="cr-i cr-i--chevron-down"></span></p>
      <div style="width: 940px">
          <ul class="list-content" id="our-research-menu"><li class="toplevel"><p><a href="/our-research/our-research-by-cancer-type" class="level2">By cancer type</a></p><ul><li><a href="/node/198836" class="level3">Brain tumours</a></li><li><a href="/node/199166" class="level3">Skin cancer</a></li><li><a href="/node/196346/" class="level3">Breast cancer</a></li><li><a href="/our-research/our-research-by-cancer-type" class="level3">All cancer types</a></li></ul></li><li class="toplevel"><p><a href="/our-progress" class="level2">Our achievements timeline</a></p><ul></ul></li><li class="toplevel"><p><a href="/our-research/our-research-by-cancer-subject" class="level2">By cancer topic</a></p><ul><li><a href="/node/206811" class="level3">New treatments</a></li><li><a href="/our-research/our-research-by-cancer-subject/our-research-on-cancer-biology" class="level3">Cancer biology</a></li><li><a href="/node/206651" class="level3">Cancer drugs</a></li><li><a href="/our-research/our-research-by-cancer-subject" class="level3">All cancer subjects</a></li></ul></li><li class="toplevel"><p><a href="/funding-for-researchers/our-research-strategy" class="level2">Our research strategy</a></p><ul></ul></li><li class="toplevel"><p><a href="/our-research/involving-animals-in-research" class="level2">Involving animals in research</a></p><ul></ul></li></ul>
      </div>
    </li><li class="mm-item"><p><a href="/funding-for-researchers" class="mm-item-link">Funding for researchers</a><span class="cr-i cr-i--chevron-down"></span></p>
      <div style="width: 940px">
          <ul class="list-content" id="funding-for-researchers-menu"><li class="toplevel"><p><a href="/funding-for-researchers" class="level2">Research opportunities</a></p><ul><li><a href="/funding-for-researchers/research-opportunities-in-basic-science-and-discovery-research" class="level3">For discovery researchers</a></li><li><a href="/funding-for-researchers/clinical-research" class="level3">For clinical researchers</a></li><li><a href="/funding-for-researchers/research-opportunities-in-population-and-behavioural-research" class="level3">For population researchers</a></li><li><a href="/funding-for-researchers/drug-discovery-and-development" class="level3">In drug discovery &amp; development</a></li><li><a href="/funding-for-researchers/research-opportunities-in-early-detection-and-diagnosis" class="level3">In early detection &amp; diagnosis</a></li><li><a href="/funding-for-researchers/develop-your-research-career" class="level3">Develop your research career</a></li></ul></li><li class="toplevel"><p><a href="/funding-for-researchers/our-funding-schemes?items_per_page=40" class="level2">Our funding schemes</a></p><ul><li><a href="/funding-for-researchers/our-funding-schemes/career-development-fellowship" class="level3">Career Development Fellowship</a></li><li><a href="/funding-for-researchers/our-funding-schemes/discovery-programme-awards" class="level3">Discovery Programme Awards</a></li><li><a href="/funding-for-researchers/our-funding-schemes/clinical-research-funding-scheme" class="level3">Clinical Research Funding Scheme</a></li><li><a href="/funding-for-researchers/our-funding-schemes/biology-to-prevention-award" class="level3">Biology to Prevention Award</a></li><li><a href="/funding-for-researchers/our-funding-schemes" class="level3">View all schemes and deadlines</a></li></ul></li><li class="toplevel"><p><a href="/funding-for-researchers/applying-for-funding" class="level2">Applying for funding</a></p><ul><li><a href="/funding-for-researchers/applying-for-funding/start-your-funding-application-online" class="level3">Start your application online</a></li><li><a href="/funding-for-researchers/applying-for-funding/how-to-make-a-successful-application" class="level3">How to make a successful application</a></li><li><a href="/funding-for-researchers/applying-for-funding/funding-committees" class="level3">Funding committees</a></li><li><a href="/funding-for-researchers/applying-for-funding/how-to-make-a-successful-application/successful-applicant-case-studies" class="level3">Successful applicant case studies</a></li></ul></li><li class="toplevel"><p><a href="/funding-for-researchers/how-we-deliver-research" class="level2">How we deliver research</a></p><ul><li><a href="/funding-for-researchers/our-research-strategy" class="level3">Our research strategy</a></li><li><a href="/funding-for-researchers/our-research-infrastructure" class="level3">Our research infrastructure</a></li><li><a href="/funding-for-researchers/research-events-and-conferences" class="level3">Events and conferences</a></li><li><a href="/funding-for-researchers/how-we-deliver-research/our-research-partnerships" class="level3">Our research partnerships</a></li><li><a href="/funding-for-researchers/facts-and-figures-about-our-research-funding" class="level3">Facts &amp; figures about our funding</a></li></ul></li><li class="toplevel"><p>More...</p><ul><li><a href="/funding-for-researchers/patient-involvement-toolkit-for-researchers" class="level3">Patient involvement toolkit for researchers</a></li><li><a href="/funding-for-researchers/how-we-deliver-research/recently-funded-awards" class="level3">Recently funded awards</a></li><li><a href="/funding-for-researchers/manage-your-research-grant" class="level3">Manage your research grant</a></li><li><a href="/home/funding-for-researchers/manage-your-research-grant/tell-us-about-new-publications" class="level3">Notify us of new publications</a></li></ul></li></ul>
      </div>
    </li><li class="mm-item"><p><a href="/get-involved/ways-to-shop" class="mm-item-link">Shop</a><span class="cr-i cr-i--chevron-down"></span></p>
      <div style="width: 940px">
          <ul class="list-content" id="shop-menu"><li class="toplevel"><p><a href="/get-involved/find-a-shop" class="level2">Find a shop</a></p><ul><li><a href="/get-involved/volunteer/volunteer-in-our-shops" class="level3">Volunteer in a shop</a></li><li><a href="/get-involved/donate/donate-goods" class="level3">Donate goods to a shop</a></li><li><a href="/get-involved/ways-to-shop/superstores" class="level3">Our superstores</a></li></ul></li><li class="toplevel"><p><a href="https://shop.cancerresearchuk.org/" class="level2">Shop online</a></p><ul><li><a href="https://shop.cancerresearchuk.org/pages/race-for-life" class="level3">Race for Life</a></li><li><a href="https://shop.cancerresearchuk.org/products/wedding-favours" class="level3">Wedding favours</a></li><li><a href="https://shop.cancerresearchuk.org/cancer-care" class="level3">Cancer Care</a></li><li><a href="https://flowershop.cancerresearchuk.org/" class="level3">Flower Shop</a></li></ul></li><li class="toplevel"><p><a href="https://www.ebay.co.uk/str/ukcancerresearch" class="level2">Our eBay store</a></p><ul><li><a href="https://www.ebay.co.uk/str/ukcancerresearch/Dresses/_i.html?_storecat=13763243016" class="level3">Dresses</a></li><li><a href="https://www.ebay.co.uk/str/ukcancerresearch/Shoes-and-Boots/_i.html?_storecat=13763242016" class="level3">Shoes and boots</a></li><li><a href="https://www.ebay.co.uk/str/ukcancerresearch/Bags-Purses/_i.html?_storecat=13869673016" class="level3">Bags and purses</a></li></ul></li></ul>
      </div>
    </li><li class="mm-item"><p><a href="/about-us/" class="mm-item-link">About us</a><span class="cr-i cr-i--chevron-down"></span></p>
      <div style="width: 940px">
          <ul class="list-content" id="about-us-menu"><li class="toplevel"><p><a href="/about-us" class="level2">What we do</a></p><ul><li><a href="/our-research" class="level3">We beat cancer</a></li><li><a href="/get-involved/how-your-support-helps" class="level3">We fundraise</a></li><li><a href="/about-us/we-develop-policy" class="level3">We develop policy</a></li><li><a href="/global-role" class="level3">Our global role</a></li></ul></li><li class="toplevel"><p><a href="/about-us/our-organisation" class="level2">Our organisation</a></p><ul><li><a href="/about-us/our-organisation/beating-cancer-sooner-our-strategy" class="level3">Our strategy</a></li><li><a href="/about-us/how-we-are-run/our-trustees" class="level3">Our Trustees</a></li><li><a href="/about-us/how-we-are-run/chief-executive-and-executive-board" class="level3">CEO and Executive Board</a></li><li><a href="/about-us/our-organisation/how-we-spend-your-money" class="level3">How we spend your money</a></li></ul></li><li class="toplevel"><p><a href="/about-us/careers" class="level2">Careers</a></p><ul><li><a href="/about-us/careers/early-in-career-opportunities" class="level3">Early careers</a></li><li><a href="/about-us/careers/teams" class="level3">Our teams</a></li><li><a href="/about-us/careers/benefits" class="level3">Benefits</a></li></ul></li><li class="toplevel"><p><a href="https://news.cancerresearchuk.org/" class="level2">Cancer news</a></p><ul><li><a href="https://news.cancerresearchuk.org/" class="level3">Cancer News</a></li><li><a href="https://news.cancerresearchuk.org/for-researchers/" class="level3">For Researchers</a></li><li><a href="https://news.cancerresearchuk.org/for-supporters/" class="level3">For Supporters</a></li></ul></li><li class="toplevel"><p>More...</p><ul><li><a href="/about-us/contact-us" class="level3">Contact us</a></li><li><a href="/about-us/press-office" class="level3">Press office</a></li><li><a href="https://publications.cancerresearchuk.org" class="level3">Publications</a></li><li><a href="/about-us/contact-us/opt-in-form" class="level3">Update your contact preferences</a></li></ul></li></ul>
      </div>
    </li></ul>
      </div>
    </div>
  </div>
      <noscript>
        <ul class="megamenu js-off">
          <!-- start: top li -->
          <li class="mm-item"><p><a class="mm-item-link" href="/about-cancer">ABOUT CANCER</a></p></li>
          <!-- end: top li -->
          <!-- ignore empty title -->
          <!-- ignore empty title -->
          <!-- ignore empty title -->
          <!-- ignore empty title -->
          <!-- start: top li -->
          <li class="mm-item"><p><a class="mm-item-link" href="/get-involved">GET INVOLVED</a></p></li>
          <!-- end: top li -->
          <!-- ignore empty title -->
          <!-- ignore empty title -->
          <!-- ignore empty title -->
          <!-- ignore empty title -->
          <!-- start: top li -->
          <li class="mm-item"><p><a class="mm-item-link" href="/cancer-info">NEWS &amp; RESOURCES</a></p></li>
          <!-- end: top li -->
          <!-- ignore empty title -->
          <!-- ignore empty title -->
          <!-- ignore empty title -->
          <!-- start: top li -->
          <li class="mm-item"><p><a class="mm-item-link" href="/science">FUNDING &amp; RESEARCH</a></p></li>
          <!-- end: top li -->
          <!-- ignore empty title -->
          <!-- ignore empty title -->
          <!-- ignore empty title -->
          <!-- ignore empty title -->
          <!-- start: top li -->
          <li class="mm-item"><p><a class="mm-item-link" href="/about-us">ABOUT US</a></p></li>
          <!-- end: top li -->
          <!-- ignore empty title -->
          <!-- ignore empty title -->
          <!-- ignore empty title -->
          <!-- ignore empty title -->
        </ul>
      </noscript>
      <!-- end: ul megamenu -->
    </div>
  </div><!-- .header-region -->
  <div id="breadcrumb">
    <div class="inner">
      <p class="element-invisible">You are here</p><div class="breadcrumb"><a href="/">Home</a><img src="/sites/all/themes/custom/cruk/images/breadcrumb-arrow.png" alt=""><a href="/health-professional" class="menu-node-unpublished menu-node-unpublished menu-node-unpublished menu-node-unpublished menu-node-unpublished">Health professional</a><img src="/sites/all/themes/custom/cruk/images/breadcrumb-arrow.png" alt=""><a href="/health-professional/treatment-and-other-post-diagnosis-issues" class="menu-node-unpublished menu-node-unpublished">Treatment and other post-diagnosis issues</a><img src="/sites/all/themes/custom/cruk/images/breadcrumb-arrow.png" alt="">Consent forms for SACT (Systemic Anti-Cancer Therapy)</div>    </div>
  </div>
</header>


<div class="page">
  <div class="wrapper no-gutter container">
    <main role="main" id="main-content" tabindex="-1">
      <!-- start of main content -->
                    <h1>Consent forms for SACT (Systemic Anti-Cancer Therapy)</h1>
                  
      
      
            
    <div class="wide_100_73_333_multi">
  <div id="panel-row-0" class="panel-row top-section no-gutter col-md-12 col-sm-12 col-xs-12">
            <div id="panel-1" class="hero-section-mid col-md-8 col-sm-8 col-xs-12">
         <div class="panel-content">
           
<div class="panel-pane pane-entity-field pane-node-field-hero">
  
    


<div class="pane-content">
  
<!-- field-image.tpl.php -->
<div class="field field-type-image">
  
  
                <div class="field-item" rel="schema:primaryImageOfPage" resource="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_narrow_resp_breakpoint_one/public/health_professional_sact.png?itok=7-qyDCk3"><img typeof="foaf:Image" src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_narrow_resp_breakpoint_one/public/health_professional_sact.png?itok=7-qyDCk3" alt="Nurse providing chemotherapy treatment to patient" title="Nurse providing chemotherapy treatment to patient"></div>
      
        </div>
</div>


</div>
         </div>
       </div>
     
            <div id="panel-2" class="cta-section col-md-4 col-sm-4 col-xs-12">
         <div class="cta">
           <div class="panel-pane pane-fieldable-panels-pane pane-current-19291 pane-promo blue-panel">
  
        <h2 class="pane-title">Useful links</h2>
    
  
  <div class="pane-content">
    <div class="fieldable-panels-pane">
    

<div class="field field-type-text-with-summary">
  
  
                <div class="field-item"> <p><a href="/about-cancer/treatment/drugs">Patient information about cancer drugsÂ </a></p>
<p><a href="/health-professional/treatment-and-other-post-diagnosis-issues/immunotherapy-and-its-side-effects/">Immunotherapy and its side effects</a>Â </p>
<p><a href="/health-professional/treatment-and-other-post-diagnosis-issues/about-cancer-registration">About cancer registration</a>Â </p>
<p><a href="/about-cancer/type">Patient information about your type of cancer</a>Â Â </p>
<p>Â </p>
 </div>
        </div>
</div>
  </div>

  
  </div>
         </div>
       </div>
       </div>

      <div id="panel-3" class="col-md-12 col-sm-12 col-xs-12">
      <div class="panel-content">
        
<div class="panel-pane pane-fieldable-panels-pane pane-current-19296 pane-bundle-fieldable-panels-pane pane-promo">
  
    


<div class="pane-content">
  <div class="fieldable-panels-pane">
    

<div class="field field-type-text-with-summary">
  
  
                <div class="field-item"> <p>We are working with Guyâs and St. Thomasâ NHS Foundation Trust to produce national standardised SACT regimen-specific consent forms.</p>
<p>We want to support clinicians in ensuring all patients are fully informed when consenting to SACT. These forms are endorsed by the UK Systemic Anti-Cancer Therapy Board (UK SACT Board).</p>
<h2>Who has approved the content in these forms?</h2>
<p>The programme is being led by a dedicated Cancer Research UK funded oncology pharmacist at Guysâ and St. Thomasâ NHS Foundation Trust.</p>
<p>All forms are independently checked by an oncology/haematology pharmacist, oncology/haematology consultant and member of the UK SACT Board.</p>
<p>The consent forms and guidance document are available to download in PDF format. Forms are grouped by tumour-site.</p>
<p>If you have specific queries or are looking for something not covered here, please email the pharmacist.</p>
<p><span class="button"><a href="mailto:alia.nizam1@nhs.net">alia.nizam1@nhs.net</a></span></p>
 </div>
        </div>
</div>
</div>


</div>
<div class="panel-separator"></div>
<div class="panel-pane pane-fieldable-panels-pane pane-current-134436 pane-bundle-fieldable-panels-pane pane-promo">
  
      <h2 class="pane-title">
  SACT Form update</h2>



<div class="pane-content">
  <div class="fieldable-panels-pane">
    

<div class="field field-type-text-with-summary">
  
  
                <div class="field-item"> <p>SACT consent forms are currently being reviewed on a rolling schedule. Please see FAQs for order of roll-out. Republication dates may exceed the date of review indicated on each form. All forms are valid until new versions are available.</p>
<h2>What's new?</h2>
<ul>
<li><strong>27th June 2025:</strong>Â Breast cancer forms reviewed and updated. Â </li>
<li><strong>18th June 2025:</strong> Acute Lymphoblastic Leukaemia (ALL): Indication updated for Blinatumomab</li>
<li><strong>18th June 2025:Â </strong>Nivolumab subcutaneous formulation updated for Bladder and Melanoma</li>
<li><strong>18th June 2025:Â </strong>New forms added for Advanced Systemic Mastocytosis (AdvSM)</li>
<li><strong>16th May 2025</strong>:Â Consent form added for Tecartus CAR T-cell therapyÂ under <a href="/health-professional/treatment-and-other-post-diagnosis-issues/consent-forms-for-sact-systemic-anti-cancer-therapy#sact_conset4">Acute Lymphoblastic Leukaemia</a></li>
<li><strong>30th April 2025:Â </strong>Oesophago-gastric cancer formsÂ  - reviewed and updated</li>
<li><strong>27th March 2025:</strong>Â Acute Myeloid Leukaemia (AML)Â  - reviewed and updated</li>
<li><strong>26th March 2025:Â </strong>Melanoma skin cancer forms - reviewed and updated</li>
<li><strong>28th January 2025: </strong>Urology- bladder: Forms reviewed and updated</li>
<li><strong>15th January 2025:Â </strong>Gynaecological cancers: Forms reviewed and updated</li>
</ul>
<p>For more information about our review plan schedule please see our frequently asked questions.</p>
 </div>
        </div>
</div>
</div>


</div>
<div class="panel-separator"></div>
<div class="panel-pane pane-fieldable-panels-pane pane-current-19301 pane-bundle-accordion-panel-pane">
  
    


<div class="pane-content">
  <div class="panel-group" id="accordion-sact_conset">

  
    <!-- accordion groups -->

    

      <div class="panel panel-default">

        <div class="panel-heading">

          <h2 class="panel-title" id="sact_conset0">
            <a data-toggle="collapse" class="collapsed" data-parent="#accordion-sact_conset" href="#collapsesact_conset0">

              Frequently Asked Questions (FAQs)            </a>
          </h2>

        </div>


        <div id="collapsesact_conset0" class="panel-collapse ">
          <div class="panel-body">
                         <h3><strong>Which consent form groupâs are available and when will they be reviewed?</strong></h3>
<p>The regimen-specific forms have been published for the following tumour site groups. Each group of forms will be reviewed on a rolling schedule every three years. The process by which each group of forms is revalidated may result in the republication dates exceeding the date of review indicated on each group of forms. All forms are valid until new versions are made available.</p>
<table border="1" cellpadding="5" cellspacing="0">
<tr>
<td><strong>Tumour site</strong></td>
<td><strong>Issue date</strong></td>
<td><strong>Review date</strong></td>
</tr>
<tr>
<td>Advanced Systemic Mastocytosis (AdvSM)</td>
<td>Jun-25</td>
<td>Jun-28</td>
</tr>
<tr>
<td>Acute Lymphoblastic Leukaemia (ALL)Â </td>
<td>Mar-24</td>
<td>Mar-27</td>
</tr>
<tr>
<td>Acute Myeloid Leukaemia</td>
<td>Â Mar-25</td>
<td>Mar-28</td>
</tr>
<tr>
<td>Brain &amp; CNS</td>
<td>Apr-23</td>
<td>Apr-26</td>
</tr>
<tr>
<td>Breast</td>
<td>Jun-25</td>
<td>Jun-28</td>
</tr>
<tr>
<td>Children &amp; Young Person ALL</td>
<td>Aug-23</td>
<td>Â Aug-26</td>
</tr>
<tr>
<td>Children &amp; Young Person Generic</td>
<td>Â Sep-22Â </td>
<td>Sep-25</td>
</tr>
<tr>
<td>Chronic Lymphocytic Leukaemia (CLL)Â </td>
<td>Nov-23</td>
<td>Nov-26</td>
</tr>
<tr>
<td>Chronic Myeloid Leukaemia (CML)</td>
<td>Â Jul-23Â </td>
<td>Jul-26</td>
</tr>
<tr>
<td>Colorectal</td>
<td>Â Jun-22Â </td>
<td>Jun-25</td>
</tr>
<tr>
<td>Gastrointestinal Stromal Tumour (GIST)Â </td>
<td>Jul-23</td>
<td>Jul-26</td>
</tr>
<tr>
<td>Generic English SACT &amp; ImmunotherapyÂ </td>
<td>Nov-23</td>
<td>Nov-26</td>
</tr>
<tr>
<td>Generic Welsh SACT &amp; ImmunotherapyÂ </td>
<td>Nov-23</td>
<td>Nov-26</td>
</tr>
<tr>
<td>GynaecologicalÂ </td>
<td>Nov-24</td>
<td>Nov-27</td>
</tr>
<tr>
<td>Head &amp; NeckÂ </td>
<td>Aug-22</td>
<td>Aug-25</td>
</tr>
<tr>
<td>Hepatobiliary</td>
<td>Sept-24</td>
<td>Sept-27</td>
</tr>
<tr>
<td>Kaposi SarcomaÂ </td>
<td>Jul-23</td>
<td>Jul-26</td>
</tr>
<tr>
<td>LungÂ </td>
<td>Oct-22</td>
<td>Oct-25</td>
</tr>
<tr>
<td>LymphomaÂ </td>
<td colspan="2" rowspan="1">In development</td>
</tr>
<tr>
<td>Multiple Myeloma (phase 1)</td>
<td>Sept-24</td>
<td>Sept-27</td>
</tr>
<tr>
<td>Multiple Myeloma (phase 2)</td>
<td colspan="2" rowspan="1">In development</td>
</tr>
<tr>
<td>Myeloproliferative Neoplasms (MPN)Â </td>
<td>Oct-24</td>
<td>Oct-27</td>
</tr>
<tr>
<td>Neuroendocrine &amp; AdrenalÂ </td>
<td>May-24</td>
<td>May-27</td>
</tr>
<tr>
<td>OesophagogastricÂ </td>
<td>May-25</td>
<td>Â May-28</td>
</tr>
<tr>
<td>Sarcoma</td>
<td>Mar-24</td>
<td>Mar-27</td>
</tr>
<tr>
<td>Skin â MelanomaÂ </td>
<td>Mar-25</td>
<td>Mar-28</td>
</tr>
<tr>
<td>Skin â Non-MelanomaÂ </td>
<td>Feb-24</td>
<td>Feb-27</td>
</tr>
<tr>
<td>Supportive MedicinesÂ </td>
<td>Jul-20</td>
<td>Jul-23</td>
</tr>
<tr>
<td>ThyroidÂ </td>
<td>Mar-22</td>
<td>Mar-25</td>
</tr>
<tr>
<td>Urology â BladderÂ </td>
<td>Jan-25</td>
<td>Jan-28</td>
</tr>
<tr>
<td>Urology â Germ CellÂ </td>
<td>Jun-24</td>
<td>Jun-27</td>
</tr>
<tr>
<td>Urology â ProstateÂ </td>
<td>Aug-22</td>
<td>Aug-25</td>
</tr>
<tr>
<td>Urology â Renal Cell CarcinomaÂ </td>
<td>Aug-22</td>
<td>Aug-25</td>
</tr>
<tr>
<td>Urology â Small CellÂ </td>
<td>Â Aug-22</td>
<td>Â Aug-25</td>
</tr>
</table>
<table border="0" cellpadding="0" cellspacing="0">
</table>
<p>Please check the website regularly (e.g. once a month) for new forms and updates.</p>
<h3><strong>What happens when a new regimen is commissioned before the consent form group is due to be revalidated?</strong></h3>
<p>We are working to develop and publish consent forms in time with publication of positive NICE (England), AWMSG (Wales), SMC (Scotland) and HSCNI (Northern Ireland) determinations.</p>
<h3><strong>What should I do if I cannot find the regimen-specific form that I need?</strong></h3>
<p>We encourage Trusts to use the generic SACT or immunotherapy forms where a regimen-specific form is not available. Please get in touch with the project lead pharmacist so that this can be discussed with the tumour-specific lead consultant for development. Contact details for the project lead pharmacist are found at the end of this document.</p>
<h3><strong>When will consent forms for the haematology groups be available?</strong></h3>
<p>CML, CLL, MPN, AML, ALL and multiple myeloma consent forms have now been published. Lymphoma consent forms are in development.</p>
<h3><strong>How have the forms been developed and what is the governance process?</strong></h3>
<p>The forms are based on the Department of Health consent form 1. The template form has been approved by the UK Systemic Anti-Cancer Therapy Board. Each hospital/Trust will need to ensure that the forms are approved for use locally by their governance or consent committee, whichever is most appropriate for the individual organisation. Please refer to the Guidance on Consent for SACT available on this website <a href="/sites/default/files/consent_guidance_doc_v2018-06.pdf">here</a>.</p>
<h3><strong>Are the consent forms a legal document?Â </strong></h3>
<p>The consent form is not a legal document, but it represents best practice and conforms with and complements the guidance documents available to clinicians taking consent. Several guidance documents have described best practice in the area of consent with respect to law, ethics, training and experience required and the need for documentation that consent has taken place.</p>
<p>We explored informal counsel with a medico-legal advisor, in response to the issue of the Montgomery judgement. The following has been taken from their reply:</p>
<div class="quote quote-centre">
âThe issue of Montgomery is much misunderstood I think in terms of what it means for individual clinicians. It does have a bearing on the legal position if a claim is made, but the standard to which individual doctor must adhere with regard to the consent process is the GMC guidance. The Montgomery judgement really only brings the legal situation in the claims process into line with what doctors have been obliged to do since this GMC guidance was issued in 2008.<br>
The most important aspect of the GMC guidance is that information about risk must be individualised for that patient. So for example, risk of cardiac events may be higher in a patient with pre-existing cardiac disease, or peripheral neuropathy may be more relevant if you are a concert pianist, as opposed to a patient who is not. These are probably the most comprehensive and patient friendly consent forms I have seen.â</div>
<p>
The consent forms are developed to ensure a high level of consistency in the information giving and discussion with the patient. Your Trust Governance and/or consent committee must agree before you use these forms.</p>
<h3><strong>How do I give a copy of the completed form to the patient?</strong></h3>
<p>The patient can be given a photocopy or print out of the completed form. For trusts using electronic consent systems, there may be different mechanisms for providing the patient with a completed form depending on the system used, such as through secure email or a mobile application. We recommend retaining the original form in the patientâs records, or a scanned copy in the patientâs electronic records.<br>
Â </p>
<h3><strong>Will the consent forms be made available electronically?</strong></h3>
<p>Due to the complexity of the IT infrastructure, numerous electronic patient records and SACT prescription systems across the NHS, the project team cannot provide one single national electronic consent solution.<br>
An electronic consent working group was subsequently formed as part of the project. The working group developed and published the âGuidance for the Implementation of CRUK SACT Consent Forms Electronicallyâ. It is intended for use by NHS SACT providers wishing introduce electronic consent to decide which electronic consent solution would be the most appropriate for their individual needs. Guidance for the configuration and maintenance of electronic consent forms, including adoption of the CRUK consent forms electronically, is provided in this document. The document can be found on the CRUK SACT consent form webpage under the accordion âGuidance on Electronic Consent for SACTâ <a href="/sites/default/files/guidance_on_electronic_consent_for_sact.pdf">here</a>.</p>
<h3><strong>Can I use the CRUK consent forms, branding and footer on our local electronic consent system?</strong></h3>
<p>The CRUK regimen-specific consent forms may be used within local electronic consent systems. As the forms have been through a robust governance process to ensure their consistency and quality, the following disclaimers should be used depending on the applicable scenario. The following disclaimers will be included in the next version of the Guidance on Electronic Consent along with CRUK brand guidelines for logo use.</p>
<p><strong>Use of the consent forms without amendments:</strong></p>
<p>The CRUK logo and consent form footer can be included in electronic consent forms where the content of the forms is used unamended in its entirety. The format, font or colours can be changed if necessary, but the text and CRUK logo should be unamended. The footer at the bottom of each page of the consent form includes the names of those who have prepared, checked and approved the forms, as well as the details of version and date.</p>
<p>In this instance, please include the following disclaimer:</p>
<div class="quote quote-centre"><em>The content of this form was developed by Cancer Research UK and Guyâs and St Thomasâ NHS Foundation Trust. Cancer Research UK and Guyâs and St Thomasâ NHS Foundation Trust will not accept any responsibility for any claim whether for damages or otherwise, or any other liability arising out of or in connection with the form or its use.</em></div>
<p><strong>When amendments are made to the consent form contents:</strong></p>
<p>Where providers base their electronic consent forms on the CRUK consent forms but change some of the content for technical or clinical reasons, the CRUK logo and consent form footer should not be used.</p>
<p>The following disclaimer should be included within the e-consent system in a way that makes it clearly visible to both clinician and patient.</p>
<div class="quote quote-centre"><em>Parts of this form are based on content developed by Cancer Research UK and Guyâs and St. Thomasâ NHS Foundation Trust. Some of that content may haveÂ been selected and/or modified by the electronic system provider, hospital trust or clinician depending on the patientâs individual circumstances. It is the responsibility of each individual organisation to ensure that relevant legal requirements and appropriate governance and safety clearance procedures within their own clinical services have been followed prior to implementation of electronic consent. Cancer Research UK and Guyâs and St. Thomasâ NHS Foundation Trust will not accept any responsibility for any claim whether for damages or otherwise, or any other liability arising out of or in connection with the form or its use.</em></div>
<h3><strong>Will the consent forms be made available in Welsh and/or other languages?</strong></h3>
<p>The generic SACT and generic immunotherapy consent forms have been translated to Welsh. It is recommended that these forms are used to supplement the English regimen-specific consent forms when a Welsh language accompaniment is required. The project team continues to investigate avenues through which the translation of consent forms can be achieved.</p>
<h3><strong>Will chemo-radiotherapy consent forms be developed?</strong></h3>
<p>These forms are designed specifically for taking consent for SACT. For instances where the SACT is given in combination with radiotherapy, the radiation therapy will need to be consented for separately. The Royal College of Radiologists (RCR) have developed national site-specific radiotherapy consent forms. These can be found <a href="https://www.rcr.ac.uk/our-services/management-service-delivery/national-radiotherapy-consent-forms/">here</a>. The RCR plan to develop chemo-radiotherapy consent forms, but this is an ongoing piece of work for which timelines have not yet been confirmed.</p>
<h3><strong>Do you have children and young people (CYP) SACT consent forms?</strong></h3>
<p>The Children and Young People Generic Form was published in 2021. The ALL in Children and Young People form was subsequently published in 2023. We subsequently plan to develop national SACT regimen-specific consent forms for TYA groups.</p>
<h3><strong>Where can I find more information about the regimen-specific consent forms?</strong></h3>
<p>Further information can be found on<a href="/www.cruk.org/sact_consent"> www.cruk.org/sact_consent</a>. You can also emailÂ <a href="mailto:alia.nizam@gstt.nhs.uk">alia.nizam@gstt.nhs.uk</a> if you have any queries and with any comments.</p>
<p><span class="button"><a href="/sites/default/files/cruk_consent_forms_faqs.pdf">Download these FAQs</a></span></p>
<p><span class="button">Last updated: 18 June 2025</span></p>
 
          </div>
        </div>

      </div>
    

      <div class="panel panel-default">

        <div class="panel-heading">

          <h2 class="panel-title" id="sact_conset1">
            <a data-toggle="collapse" class="collapsed" data-parent="#accordion-sact_conset" href="#collapsesact_conset1">

              Guidance on consent for SACT            </a>
          </h2>

        </div>


        <div id="collapsesact_conset1" class="panel-collapse ">
          <div class="panel-body">
                         <p><a href="/sites/default/files/guidance_on_consent_for_sact.pdf">Guidance on consent for SACT</a></p>
<p><a href="/sites/default/files/guidance_for_sact_remote_consent-revised_0.pdf">Guidance on remote consent for SACT</a></p>
<p><a href="http://www.healthcareimprovementscotland.org/our_work/standards_and_guidelines/sact_consent_guidance.aspx">Guidance for SACT by Healthcare Improvement Scotland </a></p>
<p><a href="/sites/default/files/guidance_on_electronic_consent_for_sact_v02.pdf">Guidance on Electronic Consent for SACT v02</a></p>
<p>Last updated: 18 June 2024</p>
 
          </div>
        </div>

      </div>
    

      <div class="panel panel-default">

        <div class="panel-heading">

          <h2 class="panel-title" id="sact_conset2">
            <a data-toggle="collapse" class="collapsed" data-parent="#accordion-sact_conset" href="#collapsesact_conset2">

              Generic forms            </a>
          </h2>

        </div>


        <div id="collapsesact_conset2" class="panel-collapse ">
          <div class="panel-body">
                         <p><a href="/sites/default/files/generic_sact_consent_v05.pdf">Generic SACT form</a></p>
<p><a href="/sites/default/files/generic_checkpoint_inhibitor_immunotherapy_consent_v03-november.pdf">Generic checkpoint inhibitor immunotherapy form</a></p>
<p><a href="/sites/default/files/welsh_generic_sact.pdf">Welsh Generic SACT form</a></p>
<p><a href="/sites/default/files/welsh_generic_immunotherapy.pdf">Welsh Generic Immunotherapy form</a></p>
<p>Last updated: 9th October 2024</p>
 
          </div>
        </div>

      </div>
    

      <div class="panel panel-default">

        <div class="panel-heading">

          <h2 class="panel-title" id="sact_conset3">
            <a data-toggle="collapse" class="collapsed" data-parent="#accordion-sact_conset" href="#collapsesact_conset3">

              Children and Young People (age 0-24 years)            </a>
          </h2>

        </div>


        <div id="collapsesact_conset3" class="panel-collapse ">
          <div class="panel-body">
                         <p><a href="/sites/default/files/children_young_people_all_v01.pdf">ALL in Children and Young People</a></p>
<p><a href="/sites/default/files/children_young_people_generic_form_v02.pdf">Children and Young people generic form</a></p>
<p><a href="/sites/default/files/children_young_people_all_welsh_v01.pdf">Welsh ALL in Children and Young People</a></p>
<p><a href="/sites/default/files/children_young_people_generic_welsh_v01.pdf">Welsh Children and Young people generic form</a></p>
<p>Last updated: 28th March 2025</p>
 
          </div>
        </div>

      </div>
    

      <div class="panel panel-default">

        <div class="panel-heading">

          <h2 class="panel-title" id="sact_conset4">
            <a data-toggle="collapse" class="collapsed" data-parent="#accordion-sact_conset" href="#collapsesact_conset4">

              Advanced Systemic Mastocytosis (AdvSM)            </a>
          </h2>

        </div>


        <div id="collapsesact_conset4" class="panel-collapse ">
          <div class="panel-body">
                         <p><a href="/sites/default/files/advsm_avapritinib.pdf">Avapritinib</a></p>
<p><a href="/sites/default/files/advsm_midostaurin.pdf">Midostaurin</a></p>
<p><span class="button"><a href="/sites/default/files/advsm_all_sact_forms.zip">Advanced Systemic Mastocytosis (AdvSM)</a></span></p>
<p>Last updated: 18 June 2025</p>
 
          </div>
        </div>

      </div>
    

      <div class="panel panel-default">

        <div class="panel-heading">

          <h2 class="panel-title" id="sact_conset5">
            <a data-toggle="collapse" class="collapsed" data-parent="#accordion-sact_conset" href="#collapsesact_conset5">

              Acute Lymphoblastic Leukaemia (ALL)            </a>
          </h2>

        </div>


        <div id="collapsesact_conset5" class="panel-collapse ">
          <div class="panel-body">
                         <p><a href="/sites/default/files/all_blinatumomab_v1.pdf">Blinatumomab</a></p>
<p><a href="/sites/default/files/all_clofarabine_cyclophosphamide_etoposide_v1.pdf">Clofarabine, Cyclophosphamide and Etoposide</a></p>
<p><a href="/sites/default/files/all_imatinib_v1.pdf">Imatinib</a></p>
<p><a href="/sites/default/files/all_inotuzumab_ozogamicin_v1.pdf">Inotuzumab Ozogamicin</a></p>
<p><a href="/sites/default/files/all_nelarabine_cyclophosphamide_etoposide_v1.pdf">Nelarabine, Cyclophosphamide and Etoposide</a></p>
<p><a href="/sites/default/files/all_nelarabine_v1.pdf">Nelarabine</a></p>
<p><a href="/sites/default/files/all_ponatinib_for_all_v1.pdf">Ponatinib </a></p>
<p><a href="/sites/default/files/tecartus_car_t-_cell_therapy.pdf">Tecartus CAR T-cell therapy</a></p>
<p><a href="/sites/default/files/all_ukall14_consolidation_1_2_4_v1.pdf">UKALL14 Consolidation 1,2 and 4</a></p>
<p><a href="/sites/default/files/all_ukall14_consolidation_3_v1.pdf">UKALL14 Consolidation 3</a></p>
<p><a href="/sites/default/files/all_ukall14_intensification_cns_prophylaxis_v1.pdf">UKALL 14 Intensification CNS Prophylaxis</a></p>
<p><a href="/sites/default/files/all_ukall14_maintenance_v1.pdf">UKALL 14 Maintenance</a></p>
<p><a href="/sites/default/files/all_ukall14_phase_1_induction_v1.pdf">UKALL 14 Phase 1 Induction</a></p>
<p><a href="/sites/default/files/all_ukall14_phase_2_induction_v1.pdf">UKALL 14 Phase 2 Induction</a></p>
<p><a href="/sites/default/files/all_ukall14_intrathecal_systemic_anti-_cancer_therapy_sact_v1.pdf">UKALL 14 Intrathecal Systemic Anti-Cancer Therapy</a></p>
<p><a href="/sites/default/files/all_ukall14_v1.pdf">UKALL 14</a></p>
<p><a href="/sites/default/files/all_ukall60_intensive_philadelphia_negative_v1.pdf">UKALL 60+ Intensive (Philadelphia Negative)</a></p>
<p><a href="/sites/default/files/all_ukall60_non_intensive_philadelphia_negative_v1.pdf">UKALL 60+ Non-Intensive Intensive (Philadelphia Negative)</a></p>
<p><a href="/sites/default/files/all_ukall60_philadelphia_positive_v1.pdf">UKALL 60+ Philadelphia Positive</a></p>
<p>Â </p>
<p><span class="button"><a href="/sites/default/files/acute_lymphoblastic_leukaemia_all.zip">Download all Acute Lymphoblastic Leukaemia (ALL) forms</a></span></p>
<p>Last updated: 16 May 2025</p>
 
          </div>
        </div>

      </div>
    

      <div class="panel panel-default">

        <div class="panel-heading">

          <h2 class="panel-title" id="sact_conset6">
            <a data-toggle="collapse" class="collapsed" data-parent="#accordion-sact_conset" href="#collapsesact_conset6">

              Acute Myeloid Leukaemia (AML)            </a>
          </h2>

        </div>


        <div id="collapsesact_conset6" class="panel-collapse ">
          <div class="panel-body">
                         <p><a href="/sites/default/files/aida_all-transretinoic_acid_and_idarubicin_v02.pdf">AIDA (All- transretinoic acid and Idarubicin)</a></p>
<p><a href="/sites/default/files/atra_-_ato_v02.pdf">ATRA + ATO</a></p>
<p><a href="/sites/default/files/atra_v02.pdf">ATRA</a></p>
<p><a href="/sites/default/files/azacitidine_v03.pdf">Azacitidine</a></p>
<p><a href="/sites/default/files/azacitidine_and_venetoclax_v02.pdf">Azacitidine +Â  Venetoclax</a></p>
<p><a href="/sites/default/files/da_daunorubicin_and_cytarabine_v02.pdf">DA (Daunorubicin and Cytarabine)</a></p>
<p><a href="/sites/default/files/etoposide_oral_v02.pdf">Etoposide (po)</a></p>
<p><a href="/sites/default/files/flag_v02.pdf">FLAG</a></p>
<p><a href="/sites/default/files/flag_idarubicin_v02.pdf">FLAG - Idarubicin</a></p>
<p><a href="/sites/default/files/gemtuzumab_ozogamicin_chemotherapy_v02.pdf">Gemtuzumab ozogamicin + chemotherapy</a></p>
<p><a href="/sites/default/files/gemtuzumab_ozogamicin_with_daunorubicin_and_cytarabine_v02.pdf">Gemtuzumab ozogamicin with daunorubicin and cytarabine</a></p>
<p><a href="/sites/default/files/gilteritinib_single_agent_v02_0.pdf">Gilteritinib</a></p>
<p><a href="/sites/default/files/high_dose_cytarabine_ara_c_v02.pdf">High dose cytarabine (ARA C)</a></p>
<p><a href="/sites/default/files/high_dose_cytarabine_ara_c_and_amsacrine_v02.pdf">High dose cytarabine (ARA C) + Amsacrine</a></p>
<p><a href="/sites/default/files/hydroxycarbamide_v02.pdf">Hydroxycarbamide</a></p>
<p><a href="/sites/default/files/ivosidenib_and_azacitidine_v01.pdf">Ivosidenib and Azacitidine</a></p>
<p><a href="/sites/default/files/liposomal_daunorubicin_and_cytarabine_vyxeos_v02.pdf">Liposomal daunorubicin + Cytarabine ( Vyxeos)</a></p>
<p><a href="/sites/default/files/low_dose_cytarabine_ara_c_v02.pdf">Low dose cytarabine ( ARA C)</a></p>
<p><a href="/sites/default/files/low_dose_cytarabine_ara_c_and_venetoclax_v02.pdf">Low dose cytarabine ( ARA C) + Venetoclax</a></p>
<p><a href="/sites/default/files/mace_amsacrine_cytarabine_etopside_v02.pdf">MACE (Amsacrine, Cytarabine, Etoposide)</a></p>
<p><a href="/sites/default/files/mec_mitoxantrone_etoposide_and_cytarabine_v02.pdf">MEC</a></p>
<p><a href="/sites/default/files/midac_mitoxantrone_and_cytarabine_v02.pdf">MidAC</a></p>
<p><a href="/sites/default/files/midostaurin_chemotherapy_da_and_high_dose_cytarabine_v02.pdf">Midostaurin + chemo (DA + HD Ara C)</a></p>
<p><a href="/sites/default/files/midostaurin_-_chemotherapy_v02.pdf">Midostaurin (+/- chemotherapy)</a></p>
<p><a href="/sites/default/files/mitoxantrone_v02.pdf">Mitoxantrone</a></p>
<p><a href="/sites/default/files/quizartinib_chemotherapy_da_high_dose_cytarabine_v01.pdf">Quizartinib + chemotherapy (DA &amp; high dose Cytarabine)</a></p>
<p><a href="/sites/default/files/sorafenib_v01.pdf">Sorafenib</a></p>
<p><span class="button"><a href="/sites/default/files/aml_cancer_sact_forms.zip">Download all AML cancer SACT forms</a></span></p>
<p>Last updated: 27th March 2025</p>
 
          </div>
        </div>

      </div>
    

      <div class="panel panel-default">

        <div class="panel-heading">

          <h2 class="panel-title" id="sact_conset7">
            <a data-toggle="collapse" class="collapsed" data-parent="#accordion-sact_conset" href="#collapsesact_conset7">

              Brain/CNS cancers            </a>
          </h2>

        </div>


        <div id="collapsesact_conset7" class="panel-collapse ">
          <div class="panel-body">
                         <p><a href="/sites/default/files/brain_carboplatin-etoposide_v01.pdf">Carboplatin-Etoposide</a></p>
<p><a href="/sites/default/files/brain_lomustine_v02.pdf">Lomustine</a></p>
<p><a href="/sites/default/files/brain_pcv_v02.pdf">Procarbazine-Lomustine-Vincristine (PCV)</a></p>
<p><a href="/sites/default/files/brain_temozolomide_v02_0.pdf">Temozolomide</a></p>
<p><a href="/sites/default/files/brain_temozolomide_rt_v02.pdf">Temozolomide+Radiotherapy</a></p>
<p><span class="button"><a href="/sites/default/files/all_brain_sact_forms_27-07.zip">Download all Brain/CNS cancers SACT forms</a></span></p>
<p>Last updated: 25th July 2023</p>
 
          </div>
        </div>

      </div>
    

      <div class="panel panel-default">

        <div class="panel-heading">

          <h2 class="panel-title" id="sact_conset8">
            <a data-toggle="collapse" class="collapsed" data-parent="#accordion-sact_conset" href="#collapsesact_conset8">

              Breast cancers            </a>
          </h2>

        </div>


        <div id="collapsesact_conset8" class="panel-collapse ">
          <div class="panel-body">
                         <p><a href="/sites/default/files/breast_abemaciclib.pdf">Abemaciclib</a></p>
<p><a href="/sites/default/files/breast_ac_doxorubicin_-_cyclophosphamide.pdf">AC (Doxorubicin - Cyclophosphamide)</a></p>
<p><a href="/sites/default/files/breast_ac_-_docetaxel.pdf">AC-Docetaxel </a></p>
<p><a href="/sites/default/files/breast_alpelisib.pdf"><span><span>Alpelisib</span></span></a></p>
<p><a href="/sites/default/files/breast_atezolizumab_-_paclitaxel_albumin-bound.pdf">Atezolizumab - Paclitaxel albumin-bound</a></p>
<p><a href="/sites/default/files/breast_capivasertib.pdf">Capivasertib</a></p>
<p><a href="/sites/default/files/breast_capecitabine.pdf">Capecitabine </a></p>
<p><a href="/sites/default/files/breast_capecitabine_-pertuzumab_-_trastuzumab.pdf">Capecitabine - Pertuzumab-Trastuzumab </a></p>
<p><a href="/sites/default/files/breast_carboplatin.pdf">Carboplatin </a></p>
<p><a href="/sites/default/files/breast_carboplatin_paclitaxeland_ec_with_pembrolizumab.pdf">Carboplatin, Paclitaxel and EC with Pembrolizumab</a></p>
<p><a href="/sites/default/files/breast_cmf.pdf">CMF </a></p>
<p><a href="/sites/default/files/breast_cyclophosphamide-methotrexate.pdf">Cyclophosphamide-Methotrexate </a></p>
<p><a href="/sites/default/files/breast_docetaxel.pdf">Docetaxel </a></p>
<p><a href="/sites/default/files/breast_docetaxel_-_capecitabine.pdf">Docetaxel-Capecitabine </a></p>
<p><a href="/sites/default/files/breast_doxorubicin.pdf">Doxorubicin</a></p>
<p><a href="/sites/default/files/breast_ec_epirubicin_-_cyclophosphamide.pdf">EC (Epirubicin-Cyclophosphamide)</a></p>
<p><a href="/sites/default/files/breast_ec-carboplatin-paclitaxel.pdf">EC-Carboplatin-Paclitaxel </a></p>
<p><a href="/sites/default/files/breast_ec-docetaxel.pdf">EC-Docetaxel </a></p>
<p><a href="/sites/default/files/breast_ec-docetaxel-trastuzumab.pdf">EC-Docetaxel-Trastuzumab</a></p>
<p><a href="/sites/default/files/breast_ec-paclitaxel.pdf">EC-Paclitaxel</a></p>
<p><a href="/sites/default/files/breast_ec-paclitaxel-trastuzumab.pdf">EC-Paclitaxel-Trastuzumab</a></p>
<p><a href="/sites/default/files/breast_ec-pph.pdf">EC-PPH</a></p>
<p><a href="/sites/default/files/breast_ec-tph.pdf">EC-TPH</a></p>
<p><a href="/sites/default/files/breast_elacestrant.pdf">Elacestrant</a></p>
<p><a href="/sites/default/files/breast_epirubicin.pdf">Epirubicin</a></p>
<p><a href="/sites/default/files/breast_epirubicin-cmf.pdf">Epirubicin-CMF</a></p>
<p><a href="/sites/default/files/breast_eribulin.pdf">Eribulin</a></p>
<p><a href="/sites/default/files/breast_everolimus.pdf">Everolimus</a></p>
<p><a href="/sites/default/files/breast_gemcitabine_and_capecitabine.pdf">Gemcitabine - Capecitabine</a></p>
<p><a href="/sites/default/files/breast_gemcitabine_-_carboplatin.pdf">Gemcitabine-Carboplatin</a></p>
<p><a href="/sites/default/files/breast_gemcitabine_-_paclitaxel.pdf">Gemcitabine-Paclitaxel</a></p>
<p><a href="/sites/default/files/breast_kadcyla_trastuzumab_emtansine.pdf">KadcylaÂ® (trastuzumab emtansine)</a></p>
<p><a href="/sites/default/files/breast_liposomal_doxorubicin_myocet.pdf">Liposomal doxorubicin (MyocetÂ®)</a></p>
<p><a href="/sites/default/files/breast_liposomal_doxorubicin_myocet-cyclophosphamide.pdf">Liposomal doxorubicin (MyocetÂ®)-Cyclophosphamide</a></p>
<p><a href="/sites/default/files/breast_mmm_mitomycin_methotrexate_and_mitoxantrone.pdf">MMM</a></p>
<p><a href="/sites/default/files/breast_neratinib.pdf">Neratinib</a></p>
<p><a href="/sites/default/files/breast_olaparib.pdf">Olaparib</a></p>
<p><a href="/sites/default/files/breast_paclitaxel_albumin-bound.pdf">Paclitaxel albumin-bound</a></p>
<p><a href="/sites/default/files/breast_paclitaxel_albumin_bound_and_carboplatin.pdf">Paclitaxel albumin-bound - Carboplatin</a></p>
<p><a href="/sites/default/files/breast_paclitaxel.pdf">Paclitaxel</a></p>
<p><a href="/sites/default/files/breast_paclitaxel_-_pertuzumab_-_trastuzumab.pdf">Paclitaxel - Pertuzumab-Trastuzumab</a></p>
<p><a href="/sites/default/files/breast_paclitaxel-trastuzumab.pdf">Paclitaxel-Trastuzumab</a></p>
<p><a href="/sites/default/files/breast_palbociclib.pdf">Palbociclib</a></p>
<p><a href="/sites/default/files/breast_pembrolizumab_and_paclitaxel.pdf"><span><span>Pembrolizumab - Paclitaxel</span></span></a></p>
<p><a href="/sites/default/files/breast_pembrolizumab_and_paclitaxel_albumin-_bound.pdf"><span><span>Pembrolizumab â Paclitaxel Albumin Bound</span></span></a></p>
<p><a href="/sites/default/files/breast_pertuzumab-trastuzumab.pdf">Pertuzumab-Trastuzumab</a></p>
<p><a href="/sites/default/files/breast_ribociclib.pdf">Ribociclib</a></p>
<p><a href="/sites/default/files/breast_sacituzumab_govitecan.pdf"><span><span>Sacituzumab Govitecan</span></span></a></p>
<p><a href="/sites/default/files/breast_talazoparib.pdf">Talazoparib</a></p>
<p><a href="/sites/default/files/breast_tc_docetaxel-cyclophosphamide.pdf">TC (Docetaxel-Cyclophosphamide)</a></p>
<p><a href="/sites/default/files/breast_tcarboh_docetaxel-carboplatin-trastuzumab.pdf">TCarboH (Docetaxel-Carboplatin-Trastuzumab)</a></p>
<p><a href="/sites/default/files/breast_tcarboph_docetaxel-carboplatin-pertuzumab-trastuzumab.pdf">TCarboPH (Docetaxel-Carboplatin-Pertuzumab-Trastuzumab)</a></p>
<p><a href="/sites/default/files/breast_tph_docetaxel-pertuzumab-trastuzumab.pdf">TPH (Docetaxel-Pertuzumab-Trastuzumab)</a></p>
<p><a href="/sites/default/files/breast_trastuzumab.pdf">Trastuzumab</a></p>
<p><a href="/sites/default/files/breast_trastuzumab_deruxtecan_enhertu.pdf">Trastuzumab Deruxtecan </a></p>
<p><a href="/sites/default/files/breast_tucatinib_trastuzumab_and_capecitabine_0.pdf">Tucatinib, trastuzumab and capecitabine</a></p>
<p><a href="/sites/default/files/breast_vinorelbine_iv.pdf">Vinorelbine (IV)</a></p>
<p><a href="/sites/default/files/breast_vinorelbine_oral.pdf">Vinorelbine (Oral) </a></p>
<p><a href="/sites/default/files/breast_vinorelbine_and_capecitabine.pdf">Vinorelbine-Capecitabine</a></p>
<p><span class="button"><a href="/sites/default/files/all_breast_cancer_sact_forms.zip">Download all Breast cancers SACT forms</a></span></p>
<p>Last updated: 27 June 2025</p>
 
          </div>
        </div>

      </div>
    

      <div class="panel panel-default">

        <div class="panel-heading">

          <h2 class="panel-title" id="sact_conset9">
            <a data-toggle="collapse" class="collapsed" data-parent="#accordion-sact_conset" href="#collapsesact_conset9">

              Chronic Lymphocytic Leukaemia (CLL)            </a>
          </h2>

        </div>


        <div id="collapsesact_conset9" class="panel-collapse ">
          <div class="panel-body">
                         <p><a href="/sites/default/files/cancer-stats/cll_acalabrutinib_v03/cll_acalabrutinib_v03.pdf">Acalabrutinib</a></p>
<p><a href="/sites/default/files/cancer-stats/cll_bendamustine_rituximab_v03/cll_bendamustine_rituximab_v03.pdf">Bendamustine â Rituximab</a></p>
<p><a href="/sites/default/files/cancer-stats/cll_chlorambucil_v02/cll_chlorambucil_v02.pdf">Chlorambucil</a></p>
<p><a href="/sites/default/files/cancer-stats/cll_chlorambucil_obinutuzumab_v02/cll_chlorambucil_obinutuzumab_v02.pdf">Chlorambucil â Obinutuzumab</a></p>
<p><a href="/sites/default/files/cancer-stats/cll_chlorambucil_rituximab_v02/cll_chlorambucil_rituximab_v02.pdf">Chlorambucil â Rituximab</a></p>
<p><a href="/sites/default/files/cancer-stats/cll_fcr_3_day_v02/cll_fcr_3_day_v02.pdf">FCR (Fludarabine â Cyclophosphamide â Rituximab) 3 Days</a></p>
<p><a href="/sites/default/files/cancer-stats/cll_fcr_5_day_v02/cll_fcr_5_day_v02.pdf">FCR (Fludarabine â Cyclophosphamide â Rituximab) 5 Days</a></p>
<p><a href="/sites/default/files/cll_ibrutinib_v03.pdf">Ibrutinib</a></p>
<p><a href="/sites/default/files/cancer-stats/cll_idelalisib_rituximab_v02/cll_idelalisib_rituximab_v02.pdf">Idelalisib â Rituximab</a></p>
<p><a href="/sites/default/files/cancer-stats/cll_venetoclax_v02/cll_venetoclax_v02.pdf">Venetoclax</a></p>
<p><a href="/sites/default/files/cll_venetoclax_ibrutinib_v01.pdf">Venetoclax â Ibrutinib</a></p>
<p><a href="/sites/default/files/cancer-stats/cll_venetoclax_rituximab_v02/cll_venetoclax_rituximab_v02.pdf">Venetoclax â Rituximab</a></p>
<p><a href="/sites/default/files/cancer-stats/cll_venetoclax_obinutuzumab_v02/cll_venetoclax_obinutuzumab_v02.pdf">Venetoclax â Obinutuzumab</a></p>
<p><a href="/sites/default/files/cancer-stats/cll_zanubritinib_v01/cll_zanubritinib_v01.pdf">Zanubrutinib</a></p>
<p><span class="button"><a href="/sites/default/files/all_cll_sact_forms-december2023.zip">Download all chronic lymphocytic leukaemia cancer SACT forms</a></span></p>
<p><span class="button">âLast update: 20th December 2023</span></p>
 
          </div>
        </div>

      </div>
    

      <div class="panel panel-default">

        <div class="panel-heading">

          <h2 class="panel-title" id="sact_conset10">
            <a data-toggle="collapse" class="collapsed" data-parent="#accordion-sact_conset" href="#collapsesact_conset10">

              Chronic Myeloid Leukaemia (CML)            </a>
          </h2>

        </div>


        <div id="collapsesact_conset10" class="panel-collapse ">
          <div class="panel-body">
                         <p><a href="/sites/default/files/cml_asciminib_v01.pdf">Asciminib</a></p>
<p><a href="/sites/default/files/cml_bosutinib_v03.pdf">Bosutinib</a></p>
<p><a href="/sites/default/files/cml_dasatinib_v03.pdf">Dasatinib</a></p>
<p><a href="/sites/default/files/cml_hydroxycarbamide_v03.pdf">Hydroxycarbamide</a></p>
<p><a href="/sites/default/files/cml_imatinib_v03.pdf">Imatinib</a></p>
<p><a href="/sites/default/files/cml_interferon_alfa_v03.pdf">Interferon-Alfa</a></p>
<p><a href="/sites/default/files/cml_nilotinib_v03.pdf">Nilotinib</a></p>
<p><a href="/sites/default/files/cml_peginterferon_alpha_v03.pdf">Peginterferon-Alfa</a></p>
<p><a href="/sites/default/files/cml_ponatinib_v03.pdf">Ponatinib</a></p>
<p><span class="button"><a href="/sites/default/files/all_cml_sact_forms_10-08.zip">Download all chronic myeloid leukaemiaÂ cancer SACT forms</a></span></p>
<p>Last updated: 10th August 2023</p>
<div class="footnote">Â </div>
 
          </div>
        </div>

      </div>
    

      <div class="panel panel-default">

        <div class="panel-heading">

          <h2 class="panel-title" id="sact_conset11">
            <a data-toggle="collapse" class="collapsed" data-parent="#accordion-sact_conset" href="#collapsesact_conset11">

              Colorectal cancer            </a>
          </h2>

        </div>


        <div id="collapsesact_conset11" class="panel-collapse ">
          <div class="panel-body">
                         <p></p><div class="media media-element-container media-default"><div id="file-1253651--2" class="file file-document file-application-pdf">

        <h2 class="element-invisible"><a href="/file/aflibercept-irinotecan-fluorouracil-folfiri">Aflibercept Irinotecan-Fluorouracil Folfiri </a></h2>
    
  
  <div class="content">
    <div class="file"><a href="/sites/default/files/colorectal_aflibercept_irinotecan-fluorouracil_folfiri_v2.pdf" type="application/pdf; length=207154" class="file-icon mime-application-pdf">Aflibercept Irinotecan-Fluorouracil Folfiri </a></div>  </div>

  
</div>
</div><div class="media media-element-container media-default"><div id="file-1253656--2" class="file file-document file-application-pdf">

        <h2 class="element-invisible"><a href="/file/bevacizumab-chemotherapy">Bevacizumab Chemotherapy </a></h2>
    
  
  <div class="content">
    <div class="file"><a href="/sites/default/files/colorectal_bevacizumab_chemotherapy_v2.pdf" type="application/pdf; length=201550" class="file-icon mime-application-pdf">Bevacizumab Chemotherapy </a></div>  </div>

  
</div>
</div><div class="media media-element-container media-default"><div id="file-1253666--2" class="file file-document file-application-pdf">

        <h2 class="element-invisible"><a href="/file/capecitabine">Capecitabine </a></h2>
    
  
  <div class="content">
    <div class="file"><a href="/sites/default/files/colorectal_capecitabine_v3.pdf" type="application/pdf; length=199699" class="file-icon mime-application-pdf">Capecitabine </a></div>  </div>

  
</div>
</div><div class="media media-element-container media-default"><div id="file-1253661--2" class="file file-document file-application-pdf">

        <h2 class="element-invisible"><a href="/file/capecitabine-mitomycin">Capecitabine Mitomycin</a></h2>
    
  
  <div class="content">
    <div class="file"><a href="/sites/default/files/colorectal_capecitabine_mitomycin_v3.pdf" type="application/pdf; length=201825" class="file-icon mime-application-pdf">Capecitabine Mitomycin</a></div>  </div>

  
</div>
</div><div class="media media-element-container media-default"><div id="file-1253671--2" class="file file-document file-application-pdf">

        <h2 class="element-invisible"><a href="/file/capecitabine-mitomycin-radiotherapy">Capecitabine-Mitomycin Radiotherapy </a></h2>
    
  
  <div class="content">
    <div class="file"><a href="/sites/default/files/colorectal_capecitabine-mitomycin_radiotherapy_v3.pdf" type="application/pdf; length=206121" class="file-icon mime-application-pdf">Capecitabine-Mitomycin Radiotherapy </a></div>  </div>

  
</div>
</div>
<p><a href="/sites/default/files/colorectal_capecitabine_radiotherapy_v3.pdf">Capecitabine and Radiotherapy</a></p>
<p></p><div class="media media-element-container media-default"><div id="file-1253681--2" class="file file-document file-application-pdf">

        <h2 class="element-invisible"><a href="/file/carboplatin-and-paclitaxel">Carboplatin and Paclitaxel</a></h2>
    
  
  <div class="content">
    <div class="file"><a href="/sites/default/files/colorectal_carboplatin_and_paclitaxel_v1.pdf" type="application/pdf; length=192771" class="file-icon mime-application-pdf">Carboplatin and Paclitaxel</a></div>  </div>

  
</div>
</div><div class="media media-element-container media-default"><div id="file-1253686--2" class="file file-document file-application-pdf">

        <h2 class="element-invisible"><a href="/file/cetuximab-chemotherapy">Cetuximab +/- Chemotherapy </a></h2>
    
  
  <div class="content">
    <div class="file"><a href="/sites/default/files/colorectal_cetuximab_and_or_chemotherapy_v2.pdf" type="application/pdf; length=200115" class="file-icon mime-application-pdf">Cetuximab +/- Chemotherapy </a></div>  </div>

  
</div>
</div><div class="media media-element-container media-default"><div id="file-1253691--2" class="file file-document file-application-pdf">

        <h2 class="element-invisible"><a href="/file/cisplatin-capecitabine">Cisplatin-Capecitabine</a></h2>
    
  
  <div class="content">
    <div class="file"><a href="/sites/default/files/colorectal_cisplatin-capecitabine_v1.pdf" type="application/pdf; length=201600" class="file-icon mime-application-pdf">Cisplatin-Capecitabine</a></div>  </div>

  
</div>
</div><div class="media media-element-container media-default"><div id="file-1253711--2" class="file file-document file-application-pdf">

        <h2 class="element-invisible"><a href="/file/cisplatin-fluorouracil">Cisplatin-Fluorouracil</a></h2>
    
  
  <div class="content">
    <div class="file"><a href="/sites/default/files/colorectal_cisplatin-fluorouracil_v2_0.pdf" type="application/pdf; length=200806" class="file-icon mime-application-pdf">Cisplatin-Fluorouracil</a></div>  </div>

  
</div>
</div>
<p><a href="/sites/default/files/colorectal_encorafenib_cetuximab_v1.pdf">Encorafenib and Cetuximab</a></p>
<p></p><div class="media media-element-container media-default"><div id="file-1253716--2" class="file file-document file-application-pdf">

        <h2 class="element-invisible"><a href="/file/fluorouracil-modified-de-gramont">Fluorouracil Modified de Gramont</a></h2>
    
  
  <div class="content">
    <div class="file"><a href="/sites/default/files/colorectal_fluorouracil_modified_de_gramont_v2.pdf" type="application/pdf; length=200399" class="file-icon mime-application-pdf">Fluorouracil Modified de Gramont</a></div>  </div>

  
</div>
</div><div class="media media-element-container media-default"><div id="file-1253721--2" class="file file-document file-application-pdf">

        <h2 class="element-invisible"><a href="/file/fluorouracil-and-folinic-acid-weekly">Fluorouracil and Folinic Acid Weekly</a></h2>
    
  
  <div class="content">
    <div class="file"><a href="/sites/default/files/colorectal_fluorouracil_and_folinic_acid_weekly_v1.pdf" type="application/pdf; length=200354" class="file-icon mime-application-pdf">Fluorouracil and Folinic Acid Weekly</a></div>  </div>

  
</div>
</div><div class="media media-element-container media-default"><div id="file-1253726--2" class="file file-document file-application-pdf">

        <h2 class="element-invisible"><a href="/file/fluorouracil-pvi-radiotherapy">Fluorouracil PVI +/- Radiotherapy</a></h2>
    
  
  <div class="content">
    <div class="file"><a href="/sites/default/files/colorectal_fluorouracil_pvi_and_or_radiotherapy_v2.pdf" type="application/pdf; length=200604" class="file-icon mime-application-pdf">Fluorouracil PVI +/- Radiotherapy</a></div>  </div>

  
</div>
</div><div class="media media-element-container media-default"><div id="file-1253731--2" class="file file-document file-application-pdf">

        <h2 class="element-invisible"><a href="/file/irinotecan-capecitabine-capiri">Irinotecan Capecitabine (CAPIRI)</a></h2>
    
  
  <div class="content">
    <div class="file"><a href="/sites/default/files/colorectal_irinotecan_capecitabine_capiri_v3.pdf" type="application/pdf; length=191033" class="file-icon mime-application-pdf">Irinotecan Capecitabine (CAPIRI)</a></div>  </div>

  
</div>
</div><div class="media media-element-container media-default"><div id="file-1253751--2" class="file file-document file-application-pdf">

        <h2 class="element-invisible"><a href="/file/irinotecan-fluorouracil-folfiri">Irinotecan Fluorouracil (FOLFIRI)</a></h2>
    
  
  <div class="content">
    <div class="file"><a href="/sites/default/files/colorectal_irinotecan_fluorouracil_folfiri_v2.pdf" type="application/pdf; length=191095" class="file-icon mime-application-pdf">Irinotecan Fluorouracil (FOLFIRI)</a></div>  </div>

  
</div>
</div><div class="media media-element-container media-default"><div id="file-1253761--2" class="file file-document file-application-pdf">

        <h2 class="element-invisible"><a href="/file/irinotecan">Irinotecan</a></h2>
    
  
  <div class="content">
    <div class="file"><a href="/sites/default/files/colorectal_irinotecan_v2.pdf" type="application/pdf; length=188462" class="file-icon mime-application-pdf">Irinotecan</a></div>  </div>

  
</div>
</div><div class="media media-element-container media-default"><div id="file-1253771--2" class="file file-document file-application-pdf">

        <h2 class="element-invisible"><a href="/file/mitomycin-fluorouracil-radiotherapy">Mitomycin-Fluorouracil Radiotherapy</a></h2>
    
  
  <div class="content">
    <div class="file"><a href="/sites/default/files/colorectal_mitomycin-fluorouracil_radiotherapy_v2_0.pdf" type="application/pdf; length=189289" class="file-icon mime-application-pdf">Mitomycin-Fluorouracil Radiotherapy</a></div>  </div>

  
</div>
</div><div class="media media-element-container media-default"><div id="file-1253776--2" class="file file-document file-application-pdf">

        <h2 class="element-invisible"><a href="/file/nivolumab-and-ipilimumab">Nivolumab and Ipilimumab</a></h2>
    
  
  <div class="content">
    <div class="file"><a href="/sites/default/files/colorectal_nivolumab_and_ipilimumab_v1.pdf" type="application/pdf; length=185947" class="file-icon mime-application-pdf">Nivolumab and Ipilimumab</a></div>  </div>

  
</div>
</div><div class="media media-element-container media-default"><div id="file-1253781--2" class="file file-document file-application-pdf">

        <h2 class="element-invisible"><a href="/file/oxaliplatin-capecitabine-capox">Oxaliplatin-Capecitabine (CAPOX) </a></h2>
    
  
  <div class="content">
    <div class="file"><a href="/sites/default/files/colorectal_oxaliplatin-capecitabine_capox_v3.pdf" type="application/pdf; length=203255" class="file-icon mime-application-pdf">Oxaliplatin-Capecitabine (CAPOX) </a></div>  </div>

  
</div>
</div><div class="media media-element-container media-default"><div id="file-1253786--2" class="file file-document file-application-pdf">

        <h2 class="element-invisible"><a href="/file/oxaliplatin-fluorouracilfolfox">Oxaliplatin-Fluorouracil_(FOLFOX) </a></h2>
    
  
  <div class="content">
    <div class="file"><a href="/sites/default/files/colorectal_oxaliplatin-fluorouracil_folfox_v2.pdf" type="application/pdf; length=203459" class="file-icon mime-application-pdf">Oxaliplatin-Fluorouracil_(FOLFOX) </a></div>  </div>

  
</div>
</div><div class="media media-element-container media-default"><div id="file-1253791--2" class="file file-document file-application-pdf">

        <h2 class="element-invisible"><a href="/file/oxaliplatin-irinotecan-fluorouracil-folfoxiri">Oxaliplatin-Irinotecan-Fluorouracil (FOLFOXIRI)</a></h2>
    
  
  <div class="content">
    <div class="file"><a href="/sites/default/files/colorectal_oxaliplatin-irinotecan-fluorouracil_folfixiri_v2.pdf" type="application/pdf; length=206240" class="file-icon mime-application-pdf">Oxaliplatin-Irinotecan-Fluorouracil (FOLFOXIRI)</a></div>  </div>

  
</div>
</div><div class="media media-element-container media-default"><div id="file-1253801--2" class="file file-document file-application-pdf">

        <h2 class="element-invisible"><a href="/file/oxaliplatin-raltitraxed-tomox">Oxaliplatin-Raltitraxed (TOMOX) </a></h2>
    
  
  <div class="content">
    <div class="file"><a href="/sites/default/files/colorectal_oxaliplatin-raltitraxed_tomox_v2.pdf" type="application/pdf; length=202132" class="file-icon mime-application-pdf">Oxaliplatin-Raltitraxed (TOMOX) </a></div>  </div>

  
</div>
</div><div class="media media-element-container media-default"><div id="file-1253821--2" class="file file-document file-application-pdf">

        <h2 class="element-invisible"><a href="/file/panitumumab-chemotherapy">Panitumumab +/- Chemotherapy </a></h2>
    
  
  <div class="content">
    <div class="file"><a href="/sites/default/files/colorectal_panitumumab_and_or_chemotherapy_v2.pdf" type="application/pdf; length=200701" class="file-icon mime-application-pdf">Panitumumab +/- Chemotherapy </a></div>  </div>

  
</div>
</div><div class="media media-element-container media-default"><div id="file-1253831--2" class="file file-document file-application-pdf">

        <h2 class="element-invisible"><a href="/file/pembrolizumab">Pembrolizumab</a></h2>
    
  
  <div class="content">
    <div class="file"><a href="/sites/default/files/colorectal_pembrolizumab_v1.pdf" type="application/pdf; length=185225" class="file-icon mime-application-pdf">Pembrolizumab</a></div>  </div>

  
</div>
</div><div class="media media-element-container media-default"><div id="file-1253841--2" class="file file-document file-application-pdf">

        <h2 class="element-invisible"><a href="/file/raltitrexed">Raltitrexed </a></h2>
    
  
  <div class="content">
    <div class="file"><a href="/sites/default/files/colorectal_raltitrexed_v2.pdf" type="application/pdf; length=197903" class="file-icon mime-application-pdf">Raltitrexed </a></div>  </div>

  
</div>
</div><div class="media media-element-container media-default"><div id="file-1253856--2" class="file file-document file-application-pdf">

        <h2 class="element-invisible"><a href="/file/regorafenib">Regorafenib </a></h2>
    
  
  <div class="content">
    <div class="file"><a href="/sites/default/files/colorectal_regorafenib_v2.pdf" type="application/pdf; length=199279" class="file-icon mime-application-pdf">Regorafenib </a></div>  </div>

  
</div>
</div><div class="media media-element-container media-default"><div id="file-1253871--2" class="file file-document file-application-pdf">

        <h2 class="element-invisible"><a href="/file/trifluridine-and-tipiracil-lonsurfr">Trifluridine and Tipiracil (lonsurfÂ®) </a></h2>
    
  
  <div class="content">
    <div class="file"><a href="/sites/default/files/colorectal_trifluridine_and_tipiracil_lonsurf_v2.pdf" type="application/pdf; length=198577" class="file-icon mime-application-pdf">Trifluridine and Tipiracil (lonsurfÂ®) </a></div>  </div>

  
</div>
</div>
<p><span class="button"><a href="/sites/default/files/colorectal_all_sact_forms-june23.zip">Download all colorectal cancer SACT forms</a></span></p>
<p>Last updated: 14 July 2022</p>
 
          </div>
        </div>

      </div>
    

      <div class="panel panel-default">

        <div class="panel-heading">

          <h2 class="panel-title" id="sact_conset12">
            <a data-toggle="collapse" class="collapsed" data-parent="#accordion-sact_conset" href="#collapsesact_conset12">

              Gastrointestinal stromal tumors (GIST)            </a>
          </h2>

        </div>


        <div id="collapsesact_conset12" class="panel-collapse ">
          <div class="panel-body">
                         <p><a href="/sites/default/files/gist_imatinib_v02.pdf">Imatinib</a></p>
<p><a href="/sites/default/files/gist_regorafenib_v02.pdf">Regorafenib</a></p>
<p><a href="/sites/default/files/gist_sunitinib_v02.pdf">Sunitinib</a></p>
<p><span class="button"><a href="/sites/default/files/gist_sact_consent_forms_-_17-08.zip">Download all gastrointestinal stromal tumours (GIST) SACT formsÂ </a></span></p>
<p><span class="button">Last updated: 18th August 2023</span></p>
 
          </div>
        </div>

      </div>
    

      <div class="panel panel-default">

        <div class="panel-heading">

          <h2 class="panel-title" id="sact_conset13">
            <a data-toggle="collapse" class="collapsed" data-parent="#accordion-sact_conset" href="#collapsesact_conset13">

              Gynaecological cancers            </a>
          </h2>

        </div>


        <div id="collapsesact_conset13" class="panel-collapse ">
          <div class="panel-body">
                         <p><a href="/sites/default/files/gynaecological_cancer_bep_v03.pdf">BEP</a></p>
<p><a href="/sites/default/files/gynaecological_cancer_bevacizumab_v03.pdf">Bevacizumab</a></p>
<p><a href="/sites/default/files/gynaecological_cancer_carboplatin_v03.pdf">Carboplatin</a></p>
<p><a href="/sites/default/files/gynaecological_cancer_carboplatin_-_etoposide_v03.pdf">Carboplatin-Etoposide</a></p>
<p><a href="/sites/default/files/gynaecological_cancer_carboplatin-_paclitaxel_v04.pdf">Carboplatin-Paclitaxel</a></p>
<p><a href="/sites/default/files/gynaecological_cancer_carboplatin-paclitaxel-dostarlimab_v01.pdf">Carboplatin-Paclitaxel - Dostarlimab</a></p>
<p><a href="/sites/default/files/gynaecological_cancer_carboplatin-paclitaxel-pembrolizumab_-_bevacizumab_v01.pdf">Carboplatin-Paclitaxel-Pembrolizumab (+/-Â Bevacizumab)</a></p>
<p><a href="/sites/default/files/gynaecological_cancer_cisplatin_v03.pdf">Cisplatin</a></p>
<p><a href="/sites/default/files/gynaecological_cancer_cisplatin_-_radiotherapy_v03.pdf">Cisplatin + Radiotherapy</a></p>
<p><a href="/sites/default/files/gynaecological_cancer_cisplatin_-_etoposide_v03.pdf">Cisplatin-Etoposide</a></p>
<p><a href="/sites/default/files/gynaecological_cancer_cisplatin_-_fluorouracil_radiotherapy_v03.pdf">Cisplatin-Fluorouracil + Radiotherapy</a></p>
<p><a href="/sites/default/files/gynaecological_cancer_cisplatin_-_paclitaxel_v04.pdf">Cisplatin-Paclitaxel</a></p>
<p><a href="/sites/default/files/gynaecological_cancer_cisplatin_-_topotecan_v03.pdf">Cisplatin-Topotecan</a></p>
<p><a href="/sites/default/files/gynaecological_cancer_cisplatin-paclitaxel-pembrolizumab_-_bevacizumab_v01.pdf">Cisplatin-Paclitaxel -Â Pembrolizumab (+/-Â Bevacizumab)</a></p>
<p><a href="/sites/default/files/gynaecological_cancer_cyclophosphamide_oral_v01.pdf">Cyclophosphamide (oral)</a></p>
<p><a href="/sites/default/files/gynaecological_cancer_dostarlimab_v01.pdf">Dostarlimab</a></p>
<p><a href="/sites/default/files/gynaecological_cancer_doxorubicin_v03.pdf">Doxorubicin</a></p>
<p><a href="/sites/default/files/gynaecological_cancer_doxorubicin_-_cisplatin_v03.pdf">Doxorubicin-Cisplatin</a></p>
<p><a href="/sites/default/files/gynaecological_cancer_etoposide_oral_v03.pdf">Etoposide (oral)</a></p>
<p><a href="/sites/default/files/gynaecological_cancer_gemcitabine_v04.pdf">Gemcitabine</a></p>
<p><a href="/sites/default/files/gynaecological_cancer_gemcitabine_-_carboplatin_v04.pdf">Gemcitabine-Carboplatin</a></p>
<p><a href="/sites/default/files/gynaecological_cancer_gemcitabine_-_cisplatin_v04.pdf">Gemcitabine-Cisplatin</a></p>
<p><a href="/sites/default/files/gynaecological_cancer_lenvatinib_-_pembrolizumab_v01.pdf">Lenvatinib - Pembrolizumab</a></p>
<p><a href="/sites/default/files/gynaecological_cancer_niraparib_v04.pdf">Niraparib</a></p>
<p><a href="/sites/default/files/gynaecological_cancer_olaparib_v03.pdf">Olaparib</a></p>
<p><a href="/sites/default/files/gynaecological_cancer_olaparib_-_bevacizumab_v01.pdf">Olaparib - Bevacizumab</a></p>
<p><a href="/sites/default/files/gynaecological_cancer_paclitaxel_v04.pdf">Paclitaxel</a></p>
<p><a href="/sites/default/files/gynaecological_cancer_pegylated_liposomal_doxorubicin_caelyx_v03.pdf">Pegylated liposomal doxorubicin (Caelyx)</a></p>
<p><a href="/sites/default/files/gynaecological_cancer_pegylated_liposomal_doxorubicin_caelyx_-_carboplatin_v03.pdf">Pegylated liposomal doxorubicin (Caelyx) - Carboplatin</a></p>
<p><a href="/sites/default/files/gynaecological_cancer_rucaparib_v02.pdf">Rucaparib</a></p>
<p><a href="/sites/default/files/gynaecological_cancer_trametinib_v01.pdf">Trametinib</a></p>
<p><span class="button"><a href="/sites/default/files/gynaecological_cancer_all_sact_forms.zip">Download all gynaecological cancers SACT forms</a></span></p>
<p>Last updated: 15 January 2025</p>
 
          </div>
        </div>

      </div>
    

      <div class="panel panel-default">

        <div class="panel-heading">

          <h2 class="panel-title" id="sact_conset14">
            <a data-toggle="collapse" class="collapsed" data-parent="#accordion-sact_conset" href="#collapsesact_conset14">

              Head and neck cancers            </a>
          </h2>

        </div>


        <div id="collapsesact_conset14" class="panel-collapse ">
          <div class="panel-body">
                         <p><a href="/sites/default/files/cancer-stats/head_and_neck_carboplatin_radiotherapy_v2/head_and_neck_carboplatin_radiotherapy_v2.pdf">Carboplatin + Radiotherapy</a></p>
<p><a href="/sites/default/files/cancer-stats/head_and_neck_carboplatin-_fluorouracil_v2/head_and_neck_carboplatin-_fluorouracil_v2.pdf">Carboplatin-Fluorouracil</a></p>
<p><a href="/sites/default/files/cancer-stats/head_and_neck_carboplatin-_paclitaxel_v2/head_and_neck_carboplatin-_paclitaxel_v2.pdf">Carboplatin-Paclitaxel</a></p>
<p><a href="/sites/default/files/cancer-stats/head_and_neck_cetuximab_v2/head_and_neck_cetuximab_v2.pdf">Cetuximab</a></p>
<p><a href="/sites/default/files/cancer-stats/head_and_neck_cetuximab-carboplatin-_fluorouracil_v1/head_and_neck_cetuximab-carboplatin-_fluorouracil_v1.pdf">Cetuximab - Carboplatin - Fluorouracil</a></p>
<p><a href="/sites/default/files/cancer-stats/head_and_neck_cetuximab-cisplatin_-fluorouracil_v1/head_and_neck_cetuximab-cisplatin_-fluorouracil_v1.pdf">Cetuximab - Cisplatin - Fluorouracil</a></p>
<p><a href="/sites/default/files/cancer-stats/head_and_neck_cetuximab_radiotherapy_v2/head_and_neck_cetuximab_radiotherapy_v2.pdf">Cetuximab + Radiotherapy</a></p>
<p><a href="/sites/default/files/cancer-stats/head_and_neck_cisplatin_radiotherapy_v2/head_and_neck_cisplatin_radiotherapy_v2.pdf">Cisplatin + Radiotherapy</a></p>
<p><a href="/sites/default/files/cancer-stats/head_and_neck_cisplatin-fluorouracil_v2/head_and_neck_cisplatin-fluorouracil_v2.pdf">Cisplatin-Fluorouracil</a></p>
<p><a href="/sites/default/files/cancer-stats/head_and_neck_docetaxel_v2/head_and_neck_docetaxel_v2.pdf">Docetaxel</a></p>
<p><a href="/sites/default/files/cancer-stats/head_and_neck_ecarbof_epirubicin-_carboplatin-_fluorouracil_v2/head_and_neck_ecarbof_epirubicin-_carboplatin-_fluorouracil_v2.pdf">ECarboF (epirubicin-carboplatin-fluorouracil)</a></p>
<p><a href="/sites/default/files/cancer-stats/head_and_neck_ecf_v2/head_and_neck_ecf_v2.pdf">ECF</a></p>
<p><a href="/sites/default/files/cancer-stats/head_and_neck_gemcitabine_-_carboplatin_v2/head_and_neck_gemcitabine_-_carboplatin_v2.pdf">Gemcitabine-Carboplatin</a></p>
<p><a href="/sites/default/files/cancer-stats/head_and_neck_gemcitabine_-_cisplatin_v2/head_and_neck_gemcitabine_-_cisplatin_v2.pdf">Gemcitabine-Cisplatin</a></p>
<p><a href="/sites/default/files/cancer-stats/head_and_neck_methotrexate_v2/head_and_neck_methotrexate_v2.pdf">Methotrexate</a></p>
<p><a href="/sites/default/files/cancer-stats/head_and_neck_nivolumab_v2/head_and_neck_nivolumab_v2.pdf">Nivolumab</a></p>
<p><a href="/sites/default/files/cancer-stats/head_and_neck_pembrolizumab_v2/head_and_neck_pembrolizumab_v2.pdf">Pembrolizumab</a></p>
<p><a href="/sites/default/files/cancer-stats/head_and_neck_tcarbof_docetaxel-_carboplatin-_fluorouracil_v2/head_and_neck_tcarbof_docetaxel-_carboplatin-_fluorouracil_v2.pdf">TCarboF (docetaxel-carboplatin-fluorouracil)</a></p>
<p><a href="/sites/default/files/cancer-stats/head_and_neck_tpf_docetaxel-_cisplatin-fluorouracil_v2/head_and_neck_tpf_docetaxel-_cisplatin-fluorouracil_v2.pdf">TPF (docetaxel-cisplatin-fluorouracil)</a></p>
<p><span class="button"><a href="/sites/default/files/head_and_neck_all_sact_forms.zip">Download all head and neck cancers SACT forms</a></span></p>
<p>Last updated: 5th September 2022</p>
 
          </div>
        </div>

      </div>
    

      <div class="panel panel-default">

        <div class="panel-heading">

          <h2 class="panel-title" id="sact_conset15">
            <a data-toggle="collapse" class="collapsed" data-parent="#accordion-sact_conset" href="#collapsesact_conset15">

              Hepato Pancreato Biliary (HPB) cancers            </a>
          </h2>

        </div>


        <div id="collapsesact_conset15" class="panel-collapse ">
          <div class="panel-body">
                         <p><a href="/sites/default/files/hcc_atezolizumab_bevacizumab_v01.pdf">Atezolizumab and Bevacizumab</a></p>
<p><a href="/sites/default/files/hpb_cabozantinib_v01.pdf">Cabozantinib</a></p>
<p><a href="/sites/default/files/hpb_capecitabine_-_radiotherapy_v01.pdf">Capecitabine +/- Radiotherapy</a></p>
<p><a href="/sites/default/files/upper_gi_hpb_doxorubicin_v1.pdf">Doxorubicin</a></p>
<p><a href="/sites/default/files/hpb_durvalumab_with_gemcitabine_and_cisplatin_v01.pdf">Durvalumab with Gemcitabine and Cisplatin</a></p>
<p><a href="/sites/default/files/fluorouracil_modified_de_gramont.pdf">Fluorouracil (Modified de Gramont)</a></p>
<p><a href="/sites/default/files/hpb_folfox_oxaliplatin_and_fluorouracil_v02.pdf">FOLFOX (Oxaliplatin and Fluorouracil)</a></p>
<p><a href="/sites/default/files/hpb_folfirinox.pdf">FOLFIRINOX</a></p>
<p><a href="/sites/default/files/upper_gi_hpb_gemcitabine_v1.pdf">Gemcitabine</a></p>
<p><a href="/sites/default/files/hpb_gemcitabine_and_capecitabine_v04.pdf">Gemcitabine-Capecitabine</a></p>
<p><a href="/sites/default/files/hpb_gemcitabine_and_carboplatin_v01.pdf">Gemcitabine and Carboplatin</a></p>
<p><a href="/sites/default/files/upper_gi_hpb_gemcitabine-cisplatin_v1.pdf">Gemcitabine and Cisplatin</a></p>
<p><a href="/sites/default/files/upper_gi_hpb_gemcitabine_-_paclitaxel_albumin-bound_abraxaner_v1.pdf">Gemcitabine-Paclitaxel albumin-bound (AbraxaneÂ®)</a></p>
<p><a href="/sites/default/files/hpb_ivosidenib_v01.pdf">Ivosidenib</a></p>
<p><a href="/sites/default/files/hcc_lenvatinib_v01.pdf">Lenvatinib</a></p>
<p><a href="/sites/default/files/hpb_pemigatinib_v01.pdf">Pemigatinib</a></p>
<p><a href="/sites/default/files/hpb_regorafenib_v01.pdf">Regorafenib</a></p>
<p><a href="/sites/default/files/upper_gi_hpb_sorafenib_v1.pdf">Sorafenib</a></p>
<p><span class="button"><a href="/sites/default/files/upper_gi_hpb_all_sact_forms.zip">Download allÂ Hepato Pancreato Biliary (HPB) SACT forms</a></span></p>
<p><span class="button">Last updated: 9th October 2024</span></p>
 
          </div>
        </div>

      </div>
    

      <div class="panel panel-default">

        <div class="panel-heading">

          <h2 class="panel-title" id="sact_conset16">
            <a data-toggle="collapse" class="collapsed" data-parent="#accordion-sact_conset" href="#collapsesact_conset16">

              Kaposi sarcoma            </a>
          </h2>

        </div>


        <div id="collapsesact_conset16" class="panel-collapse ">
          <div class="panel-body">
                         <p><a href="/sites/default/files/kaposi_sarcoma_paclitaxel_v02.pdf">Paclitaxel</a></p>
<p><a href="/sites/default/files/kaposi_sarcoma_pegylated_liposomal_doxorubicin_caelyx_v02.pdf">Pegylated Liposomal Doxorubicin (Caelyx)</a></p>
<p><span class="button"><a href="/sites/default/files/all-kaposi-sarcoma-forms-10-08-23.zip">Download all Kaposi Sarcoma SACT forms</a></span></p>
<p><span class="button">Last updated 10th August 2023</span></p>
 
          </div>
        </div>

      </div>
    

      <div class="panel panel-default">

        <div class="panel-heading">

          <h2 class="panel-title" id="sact_conset17">
            <a data-toggle="collapse" class="collapsed" data-parent="#accordion-sact_conset" href="#collapsesact_conset17">

              Lung cancer            </a>
          </h2>

        </div>


        <div id="collapsesact_conset17" class="panel-collapse ">
          <div class="panel-body">
                         <p><a href="/sites/default/files/cancer-stats/lung_afatinib_v2/lung_afatinib_v2.pdf">Afatinib</a></p>
<p><a href="/sites/default/files/cancer-stats/lung_alectinib_v1/lung_alectinib_v1.pdf">Alectinib</a></p>
<p><a href="/sites/default/files/cancer-stats/lung_atezolizumab_bevacizumab_carboplatin_and_paclitaxel_v1/lung_atezolizumab_bevacizumab_carboplatin_and_paclitaxel_v1.pdf">Atezolizumab, bevacizumab, carboplatin and paclitaxel</a></p>
<p><a href="/sites/default/files/cancer-stats/lung_atezolizumab_carboplatin_and_etoposide_v1/lung_atezolizumab_carboplatin_and_etoposide_v1.pdf">Atezolizumab, carboplatin and etoposide</a></p>
<p><a href="/sites/default/files/cancer-stats/lung_atezolizumab_v2/lung_atezolizumab_v2.pdf">Atezolizumab</a></p>
<p><a href="/sites/default/files/cancer-stats/lung_brigatinib_v1/lung_brigatinib_v1.pdf">Brigatinib</a></p>
<p><a href="/sites/default/files/cancer-stats/lung_cap_v2/lung_cap_v2.pdf">CAP (cyclophosphamide-doxorubicin-cisplatin)</a></p>
<p><a href="/sites/default/files/cancer-stats/lung_carboplatin_-_pemetrexed_-_pembrolizumab_v1/lung_carboplatin_-_pemetrexed_-_pembrolizumab_v1.pdf">Carboplatin, pemetrexed and pembrolizumab</a></p>
<p><a href="/sites/default/files/cancer-stats/lung_carboplatin-_paclitaxel-pembrolizumab_v1/lung_carboplatin-_paclitaxel-pembrolizumab_v1.pdf">Carboplatin, paclitaxel and pembrolizumab</a></p>
<p><a href="/sites/default/files/cancer-stats/lung_carboplatin-etoposide_v2/lung_carboplatin-etoposide_v2.pdf">Carboplatin-Etoposide</a></p>
<p><a href="/sites/default/files/cancer-stats/lung_carboplatin-paclitaxel_v2/lung_carboplatin-paclitaxel_v2.pdf">Carboplatin-Paclitaxel</a></p>
<p><a href="/sites/default/files/cancer-stats/lung_carboplatin-pemetrexed_v2/lung_carboplatin-pemetrexed_v2.pdf">Carboplatin-Pemetrexed</a></p>
<p><a href="/sites/default/files/lung_carboplatin_vinorelbine_v04.pdf">Carboplatin-Vinorelbine</a></p>
<p><a href="/sites/default/files/cancer-stats/lung_cav_v2/lung_cav_v2.pdf">CAV (cyclophosphamide-doxorubicin-vincristine)</a></p>
<p><a href="/sites/default/files/cancer-stats/lung_ceritinib_v2/lung_ceritinib_v2.pdf">Ceritinib</a></p>
<p><a href="/sites/default/files/cancer-stats/lung_cisplatin_-_etoposide_v2/lung_cisplatin_-_etoposide_v2.pdf">Cisplatin-Etoposide</a></p>
<p><a href="/sites/default/files/cancer-stats/lung_cisplatin-_pemetrexed_v2/lung_cisplatin-_pemetrexed_v2.pdf">Cisplatin-Pemetrexed</a></p>
<p><a href="/sites/default/files/cancer-stats/lung_cisplatin-pemetrexed_-_pembrolizumab_v1/lung_cisplatin-pemetrexed_-_pembrolizumab_v1.pdf">Cisplatin- pemetrexed - pembrolizumab</a></p>
<p><a href="/sites/default/files/lung_cisplatin_vinorelbine_v04.pdf">Cisplatin-Vinorelbine</a></p>
<p><a href="/sites/default/files/cancer-stats/lung_crizotinib_v2/lung_crizotinib_v2.pdf">Crizotinib</a></p>
<p><a href="/sites/default/files/cancer-stats/lung_dacomitinib_v1/lung_dacomitinib_v1.pdf">Dacomitinib</a></p>
<p><a href="/sites/default/files/lung_dabrafenib_and_trametinib_v01.pdf">Dabrafenib and Trametinib</a></p>
<p><a href="/sites/default/files/cancer-stats/lung_docetaxel_v2/lung_docetaxel_v2.pdf">Docetaxel</a></p>
<p><a href="/sites/default/files/cancer-stats/lung_durvalumab_v1/lung_durvalumab_v1.pdf">Durvalumab</a></p>
<p><a href="/sites/default/files/cancer-stats/lung_erlotinib_v2/lung_erlotinib_v2.pdf">Erlotinib</a></p>
<p><a href="/sites/default/files/cancer-stats/lung_gefitinib_v2/lung_gefitinib_v2.pdf">Gefitinib</a></p>
<p><a href="/sites/default/files/cancer-stats/lung_gemcitabine_v2/lung_gemcitabine_v2.pdf">Gemcitabine</a></p>
<p><a href="/sites/default/files/cancer-stats/lung_gemcitabine_-_carboplatin_v2/lung_gemcitabine_-_carboplatin_v2.pdf">Gemcitabine-Carboplatin</a></p>
<p><a href="/sites/default/files/cancer-stats/lung_gemcitabin_-_cisplatin_v2/lung_gemcitabin_-_cisplatin_v2.pdf">Gemcitabine-Cisplatin</a></p>
<p><a href="/sites/default/files/lung_ipilimumab_and_nivolumab_v01.pdf">Ipilimumab and Nivolumab</a></p>
<p><a href="/sites/default/files/cancer-stats/lung_larotrectinib_v1/lung_larotrectinib_v1.pdf">Larotrectinib</a></p>
<p><a href="/sites/default/files/cancer-stats/lung_lorlatinib_v1/lung_lorlatinib_v1.pdf">Lorlatinib</a></p>
<p><a href="/sites/default/files/cancer-stats/lung_nintedanib-docetaxel_v2/lung_nintedanib-docetaxel_v2.pdf">Nintedanib-Docetaxel</a></p>
<p><a href="/sites/default/files/cancer-stats/lung_nivolumab_v2/lung_nivolumab_v2.pdf">Nivolumab</a></p>
<p><a href="/sites/default/files/lung_nivolumab_carboplatin_and_pemetrexed_v01.pdf">Nivolumab, Carboplatin and Pemetrexed</a></p>
<p><a href="/sites/default/files/lung_nivolumab_paclitaxel_and_carboplatin_v01.pdf">Nivolumab, Paclitaxel and Carboplatin</a></p>
<p><a href="/sites/default/files/cancer-stats/lung_osimertinib_v2/lung_osimertinib_v2.pdf">Osimertinib</a></p>
<p><a href="/sites/default/files/cancer-stats/lung_pembrolizumab_v2/lung_pembrolizumab_v2.pdf">Pembrolizumab</a></p>
<p><a href="/sites/default/files/cancer-stats/lung_pemetrexed_maintenance_v2/lung_pemetrexed_maintenance_v2.pdf">Pemetrexed (maintenance)</a></p>
<p><a href="/sites/default/files/cancer-stats/lung_ramucirumab-docetaxel_v2/lung_ramucirumab-docetaxel_v2.pdf">Ramucirumab-Docetaxel</a></p>
<p><a href="/sites/default/files/cancer-stats/lung_selpercatinib_v1/lung_selpercatinib_v1.pdf">Selpercatinib</a></p>
<p><a href="/sites/default/files/cancer-stats/lung_sotorasib_v1/lung_sotorasib_v1.pdf">Sotorasib</a></p>
<p><a href="/sites/default/files/lung_tepotinib_v01.pdf">Tepotinib</a></p>
<p><a href="/sites/default/files/cancer-stats/lung_topotecan_oral_v2/lung_topotecan_oral_v2.pdf">Topotecan (oral)</a></p>
<p><a href="/sites/default/files/lung_vinorelbine_iv_v04.pdf">Vinorelbine (IV)</a></p>
<p><a href="/sites/default/files/lung_vinorelbine_oral_v04.pdf">Vinorelbine (oral)</a></p>
<p><span class="button"><a href="/sites/default/files/lung_sact_consent_forms-all-17-08.zip">Download all lung cancer SACT forms</a></span></p>
<p>Last updated: 10th October 2024</p>
 
          </div>
        </div>

      </div>
    

      <div class="panel panel-default">

        <div class="panel-heading">

          <h2 class="panel-title" id="sact_conset18">
            <a data-toggle="collapse" class="collapsed" data-parent="#accordion-sact_conset" href="#collapsesact_conset18">

              Melanoma skin cancer            </a>
          </h2>

        </div>


        <div id="collapsesact_conset18" class="panel-collapse ">
          <div class="panel-body">
                         <p><a href="/sites/default/files/dabrafenib.pdf">Dabrafenib</a></p>
<p><a href="/sites/default/files/dabrafenib_and_trametinib.pdf">Dabrafenib-Trametinib</a></p>
<p><a href="/sites/default/files/dacarbazine.pdf">Dacarbazine</a></p>
<p><a href="/sites/default/files/encorafenib_and_binimetinib.pdf">Encorafenib-Binimetinib</a></p>
<p><a href="/sites/default/files/ipilimumab.pdf">Ipilimumab</a></p>
<p><a href="/sites/default/files/ipilimumab_and_nivolumab.pdf">Ipilimumab-Nivolumab</a></p>
<p><a href="/sites/default/files/melanoma_nivolumab.pdf">Nivolumab</a></p>
<p><a href="/sites/default/files/melanoma_nivolumab_with_relatlimab_v01.pdf">Nivolumab with Relatlimab</a></p>
<p><a href="/sites/default/files/pembrolizumab.pdf">Pembrolizumab</a></p>
<p><a href="/sites/default/files/talimogene_laherparevec_imlygic_or_t-vec-v03.pdf">Talimogene laherparepvec (ImlygicÂ®)</a></p>
<p><span class="button"><a href="/sites/default/files/melanoma_sact_forms.zip">Download all melanoma skin cancer SACT forms</a></span></p>
<p>Last updated: 26 March 2025</p>
 
          </div>
        </div>

      </div>
    

      <div class="panel panel-default">

        <div class="panel-heading">

          <h2 class="panel-title" id="sact_conset19">
            <a data-toggle="collapse" class="collapsed" data-parent="#accordion-sact_conset" href="#collapsesact_conset19">

              Multiple Myeloma            </a>
          </h2>

        </div>


        <div id="collapsesact_conset19" class="panel-collapse ">
          <div class="panel-body">
                         <p><a href="/sites/default/files/multiple_myeloma_vcd_bortezomib_cyclophosphamide_and_dexamethasone_v01.pdf">VCd (Bortezomib, Cyclophosphamide and Dexamethasone)</a></p>
<p><a href="/sites/default/files/mutiple_myeloma_bortezomib_and_dexamethasone_v01.pdf">Bortezomib and Dexamethasone</a></p>
<p><a href="/sites/default/files/mutiple_myeloma_krd_carfilzomib_lenalidomide_and_dexamethasone_v01.pdf">KRd (Carfilzomib, Lenalidomide and Dexamethasone)</a></p>
<p><a href="/sites/default/files/mutiple_myeloma_cyclophosphamide_oral_-_dexamethasone_v01.pdf">Cyclophosphamide (Oral) +/- Dexamethasone</a></p>
<p><a href="/sites/default/files/mutiple_myeloma_daratumumab_monotherapy_v01.pdf">Daratumumab (Monotherapy)</a></p>
<p><a href="/sites/default/files/mutiple_myeloma_dvd_daratumumab_bortezomib_and_dexamethasone_v01.pdf">DVd (Daratumumab, Bortezomib and Dexamethasone)</a></p>
<p><a href="/sites/default/files/multiple_myeloma_dvtd_daratumumab_bortezomib_thalidomide_and_dexamethasone_v01.pdf">DVTd (Daratumumab, Bortezomib, Thalidomide and Dexamethasone)</a></p>
<p><a href="/sites/default/files/mutiple_myeloma_drd_daratumumab_lenalidomide_and_dexamethasone_v01.pdf">DRd (Daratumumab, Lenalidomide and Dexamethasone)</a></p>
<p><a href="/sites/default/files/mutiple_myeloma_isatuximab_pomalidomide_and_dexamethasone_v01.pdf">Isatuximab, Pomalidomide and Dexamethasone</a></p>
<p><a href="/sites/default/files/mutiple_myeloma_ird_ixazomib_lenalidomide_and_dexamethasone_v01.pdf">IRd (Ixazomib, Lenalidomide and Dexamethasone)</a></p>
<p><a href="/sites/default/files/mutiple_myeloma_lenalidomide_maintenance_v01.pdf">Lenalidomide (Maintenance)</a></p>
<p><a href="/sites/default/files/mutiple_myeloma_lenalidomide_and_dexamethasone_v01.pdf">Lenalidomide and Dexamethasone</a></p>
<p><a href="/sites/default/files/mutiple_myeloma_pcd_pomalidomide_cyclophosphamide_and_dexamethasone_v01.pdf">PCd (Pomalidomide, Cyclophosphamide and Dexamethasone)</a></p>
<p><a href="/sites/default/files/mutiple_myeloma_pomalidomide_and_dexamethasone_v01.pdf">Pomalidomide and Dexamethasone</a></p>
<p><span class="button"><a href="/sites/default/files/multiple_myeloma_full_list_of_sact_forms.zip">Download all Multiple Myeloma SACT forms</a></span></p>
<p><span class="button">âLast updated: 18 September 2024</span></p>
<p>Given the substantial number of treatment regimens for Multiple Myeloma, consent forms for the commonly used regimens have been prioritised and uploaded. The remaining forms are in progress and will be accessible in due course,</p>
 
          </div>
        </div>

      </div>
    

      <div class="panel panel-default">

        <div class="panel-heading">

          <h2 class="panel-title" id="sact_conset20">
            <a data-toggle="collapse" class="collapsed" data-parent="#accordion-sact_conset" href="#collapsesact_conset20">

              Myeloproliferative Neoplasms (MPN)            </a>
          </h2>

        </div>


        <div id="collapsesact_conset20" class="panel-collapse ">
          <div class="panel-body">
                         <p><a href="/sites/default/files/mpn_anagrelide_v02.pdf">Anagrelide</a></p>
<p><a href="/sites/default/files/mpn_busulfan_v02.pdf">Busulfan</a></p>
<p><a href="/sites/default/files/mpn_fedratinib_v01.pdf">Fedratinib</a></p>
<p><a href="/sites/default/files/mpn_hydroxycarbamide_v02.pdf">Hydroxycarbamide</a></p>
<p><a href="/sites/default/files/mpn_imatinib_v02.pdf">Imatinib</a></p>
<p><a href="/sites/default/files/mpn_lenalidomide_v01.pdf">Lenalidomide</a></p>
<p><a href="/sites/default/files/mpn_momelotinib_v01.pdf">Momelotinib</a></p>
<p><a href="/sites/default/files/mpn_peginterferon_alpha_v02.pdf">Peginterferon Alpha</a></p>
<p><a href="/sites/default/files/mpn_ruxolitinib_v02.pdf">Ruxolitinib</a></p>
<p><a href="/sites/default/files/mpn_thalidomide_v02.pdf">Thalidomide</a></p>
<p><span class="button"><a href="/sites/default/files/myeloproliferative_neoplasms_mpn_all_sact_forms.zip">Download allÂ Myeloproliferative Neoplasms (MPN) SACT forms</a></span></p>
<p><span class="button">âLast updated: 29 October 2024</span></p>
 
          </div>
        </div>

      </div>
    

      <div class="panel panel-default">

        <div class="panel-heading">

          <h2 class="panel-title" id="sact_conset21">
            <a data-toggle="collapse" class="collapsed" data-parent="#accordion-sact_conset" href="#collapsesact_conset21">

              Neuroendocrine and adrenal cancers            </a>
          </h2>

        </div>


        <div id="collapsesact_conset21" class="panel-collapse ">
          <div class="panel-body">
                         <p><a href="/sites/default/files/nec_and_adrenal_capecitabine_and_streptozocin_v03.pdf"><span><span>Capecitabine and Streptozocin</span></span></a></p>
<p><span><span><span><a href="/sites/default/files/nec_and_adrenal_capecitabine_and_temozolomide_v03.pdf">Capecitabine and Temozolomide</a> </span></span></span></p>
<p><a href="/sites/default/files/cancer-stats/neuroendocrine_and_adrenal_carboplatin-etoposide_v1/neuroendocrine_and_adrenal_carboplatin_and_etoposide_v02.pdf">Carboplatin and Etoposide</a></p>
<p><a href="/sites/default/files/cancer-stats/neuroendocrine_and_adrenal_cisplatin-etoposide_v1/neuroendocrine_and_adrenal_cisplatin_and_etoposide_v02.pdf">Cisplatin and Etoposide</a></p>
<p><a href="/sites/default/files/cancer-stats/neuroendocrine_and_adrenal_cvd_v1/neuroendocrine_and_adrenal_cyclophosphamide_vincristine_dacarbazine_cvd_v02.pdf">Cyclophosphamide, Vincristine and Dacarbazine (CVD)</a></p>
<p><a href="/sites/default/files/cancer-stats/neuroendocrine_and_adrenal_edp-_mitotane_v1/neuroendocrine_and_adrenal_etoposide_doxorubicin_cisplatin_edp_-_mitotane_v02.pdf">Etoposide, Doxorubicin, Cisplatin (EDP) +/- Mitotane</a></p>
<p><a href="/sites/default/files/cancer-stats/neuroendocrine_and_adrenal_everolimus_v1/neuroendocrine_and_adrenal_everolimus_v02.pdf">Everolimus</a></p>
<p><a href="/sites/default/files/neuroendocrine_and_adrenal_fluorouracil_carboplatin_and_streptozocin_fcarbost_v01.pdf"><span><span>Fluorouracil, Carboplatin and Streptozocin (FCarboSt)</span></span></a></p>
<p><a href="/sites/default/files/cancer-stats/neuroendocrine_and_adrenal_streptozocin-cisplatin-fluorouracil_v1/neuroendocrine_and_adrenal_fluorouracil_cisplatin_and_streptozocin_fcisst_v02.pdf"><span><span>Fluorouracil, Cisplatin and Streptozocin (FCisSt)</span></span></a></p>
<p><a href="/sites/default/files/cancer-stats/neuroendocrine_and_adrenal_folfiri_v1/neuroendocrine_and_adrenal_fluorouracil_and_irinotecan_folfiri_v02.pdf"><span><span>Fluorouracil and Irinotecan (FOLFIRI)</span></span></a></p>
<p><a href="/sites/default/files/nec_and_adrenal_gemcitabine_and_capecitabine_v02.pdf"><span><span>Gemcitabine and Capecitabine</span></span></a></p>
<p><a href="/sites/default/files/cancer-stats/neuroendocrine_and_adrenal_mitotane_v1/neuroendocrine_and_adrenal_mitotane_v02.pdf">Mitotane</a></p>
<p><a href="/sites/default/files/neuroendocrine_and_adrenal_oxaliplatin_irinotecan_and_fluorouracil_folfoxiri_v01.pdf"><span><span>Oxaliplatin, Irinotecan and Fluorouracil (FOLFOXIRI)</span></span></a></p>
<p><a href="/sites/default/files/cancer-stats/neuroendocrine_and_adrenal_sunitinib_v1/neuroendocrine_and_adrenal_sunitinib-v02.pdf">Sunitinib</a></p>
<p><a href="/sites/default/files/cancer-stats/neuroendocrine_and_adrenal_temozolomide_v1/neuroendocrine_and_adrenal_temozolomide_v02.pdf">Temozolomide</a></p>
<p><a href="/sites/default/files/neuroendocrine_and_adrenal_177-lutetium_dotatate_v01.pdf"><span><span>177-Lutetium Dotatate</span></span></a></p>
<p><span class="button"><a href="/sites/default/files/neuroendocrine_and_adrenal_folfiri_may24.zip">Download allÂ Neuroendocrine and adrenal cancers SACT forms</a></span></p>
<p>The published forms listed here are not exhaustive for neuroendocrine cancers. They reflect mostly (but not exclusively) those regimens for gastroenteropancreatic neuroendocrine tumours.Â <br>
The regimen-specific consent forms for neuroendocrine cancers of other areas of the body can be found within their respective anatomical groups.</p>
<p>Last updated: 14 May 2024</p>
 
          </div>
        </div>

      </div>
    

      <div class="panel panel-default">

        <div class="panel-heading">

          <h2 class="panel-title" id="sact_conset22">
            <a data-toggle="collapse" class="collapsed" data-parent="#accordion-sact_conset" href="#collapsesact_conset22">

              Oesophago-gastric cancers            </a>
          </h2>

        </div>


        <div id="collapsesact_conset22" class="panel-collapse ">
          <div class="panel-body">
                         <p><a href="/sites/default/files/og_capecitabine_with_radiotherapy_v03.pdf">Capecitabine with Radiotherapy</a></p>
<p><a href="/sites/default/files/og_carboplatin_and_capecitabine_with_or_without_radiotherapy_v01.pdf">Carboplatin and Capecitabine +/- Radiotherapy</a></p>
<p><a href="/sites/default/files/og_carboplatin_and_fluorouracil_with_or_without_radiotherapy_v01.pdf">Carboplatin and Fluorouracil +/- Radiotherapy</a></p>
<p><a href="/sites/default/files/og_capox_v02.pdf">CAPOX (Capecitabine and Oxaliplatin)</a></p>
<p><a href="/sites/default/files/og_cisplatin_and_capecitabine_with_or_without_radiotherapy_v03.pdf">Cisplatin and Capecitabine +/- Radiotherapy</a></p>
<p><a href="/sites/default/files/og_cisplatin_and_fluorouracil_with_or_without_radiotherapy_v02.pdf">Cisplatin and Fluorouracil +/- Radiotherapy</a></p>
<p><a href="/sites/default/files/og_cisplatin_capecitabine_and_trastuzumab_v03.pdf">Cisplatin-Capecitabine-Trastuzumab</a></p>
<p><a href="/sites/default/files/og_cisplatin_fluorouracil_and_trastuzumab_v02.pdf">Cisplatin-Fluorouracil-Trastuzumab</a></p>
<p><a href="/sites/default/files/og_fluorouracil_pvi_with_radiotherapy_v02.pdf">Fluorouracil PVI + Radiotherapy</a></p>
<p><a href="/sites/default/files/og_folfox_with_or_without_radiotherapy_v02.pdf">FOLFOX (Fluorouracil and Oxaliplatin) +/- Radiotherapy</a></p>
<p><a href="/sites/default/files/og_folfiri_v02.pdf">FOLFIRI (Fluorouracil and Irinotecan)</a></p>
<p><a href="/sites/default/files/og_flot_v02.pdf">FLOT (Docetaxel, Fluorouracil and Oxaliplatin)</a></p>
<p><a href="/sites/default/files/og_hof_v01.pdf">HOF (Trastuzumab, Oxaliplatin and Fluorouracil)</a></p>
<p><a href="/sites/default/files/og_hox_v01.pdf">HOX (Capecitabine, Oxaliplatin and Trastuzumab)</a></p>
<p><a href="/sites/default/files/og_irinotecan_v02.pdf">Irinotecan</a></p>
<p><a href="/sites/default/files/og_nivolumab_v01.pdf">Nivolumab</a></p>
<p><a href="/sites/default/files/og_nivolumab_with_capox_v01.pdf">Nivolumab with CAPOX (Capecitabine and Oxaliplatin)</a></p>
<p><a href="/sites/default/files/og_nivolumab_with_folfox_v01.pdf">Nivolumab with FOLFOX (Fluorouracil and Oxaliplatin)</a></p>
<p><a href="/sites/default/files/og_paclitaxel_v02.pdf">Paclitaxel</a></p>
<p><a href="/sites/default/files/og_paclitaxel_and_carboplatin_with_radiotherapy_v02.pdf">Paclitaxel and Carboplatin +/- Radiotherapy</a></p>
<p><a href="/sites/default/files/og_pembrolizumab_v01.pdf">Pembrolizumab</a></p>
<p><a href="/sites/default/files/og_pembrolizumab_with_capox_v01.pdf">Pembrolizumab with CAPOX (Capecitabine and Oxaliplatin)</a></p>
<p><a href="/sites/default/files/og_pembrolizumab_with_folfox_v01.pdf">Pembrolizumab with FOLFOX (Fluorouracil and Oxaliplatin)</a></p>
<p><a href="/sites/default/files/og_trifluridine_tipiracil_v01.pdf">Trifluridine and Tipiracil (Lonsurf)</a></p>
<p><span class="button"><a href="/sites/default/files/oesophago-gastric_cancer_all_sact.zip">Download all oesophago-gastric cancers SACT formsÂ </a></span></p>
<p><span class="button">Last updated: 30 April 2025</span></p>
 
          </div>
        </div>

      </div>
    

      <div class="panel panel-default">

        <div class="panel-heading">

          <h2 class="panel-title" id="sact_conset23">
            <a data-toggle="collapse" class="collapsed" data-parent="#accordion-sact_conset" href="#collapsesact_conset23">

              Sarcoma            </a>
          </h2>

        </div>


        <div id="collapsesact_conset23" class="panel-collapse ">
          <div class="panel-body">
                         <p><a href="/sites/default/files/sarcoma_carboplatin_and_etoposide_v01.pdf">Carboplatin - Etoposide</a></p>
<p><a href="/sites/default/files/sarcoma_cyclophosphamide_and_etoposide_v01.pdf">Cyclophosphamide - Etoposide</a></p>
<p><a href="/sites/default/files/sarcoma_cyclophosphamide_oral_and_prednisolone_v01.pdf">Cyclophosphamide - Oral prednisolone</a></p>
<p><a href="/sites/default/files/sarcoma_cyclophosphamide_and_topotecan_v01.pdf">Cyclophosphamide - Topotecan</a></p>
<p><a href="/sites/default/files/sarcoma_dacarbazine_v01.pdf">Dacarbazine</a></p>
<p><a href="/sites/default/files/sarcoma_doxorubicin_and_cisplatin_v01.pdf">Doxorubicin - Cisplatin</a></p>
<p><a href="/sites/default/files/sarcoma_doxorubicin_and_dacarbazine_v01.pdf">Doxorubicin - Dacarbazine</a></p>
<p><a href="/sites/default/files/sarcoma_doxorubicin_and_ifosfamide_v01.pdf">Doxorubicin - Ifosfamide</a></p>
<p><a href="/sites/default/files/sarcoma_doxorubicin_v01.pdf">Doxorubicin</a></p>
<p><a href="/sites/default/files/sarcoma_etoposide_oral_v01.pdf">Etoposide (Oral)</a></p>
<p><a href="/sites/default/files/sarcoma_gemcitabine_and_dacarbazine_v01_0.pdf">Gemcitabine - Dacarbazine</a></p>
<p><a href="/sites/default/files/sarcoma_gemcitabine_and_docetaxel_v01_0.pdf">Gemcitabine - Docetaxel</a></p>
<p><a href="/sites/default/files/sarcoma_gemcitabine_v01.pdf">Gemcitabine</a></p>
<p><a href="/sites/default/files/sarcoma_ie_and_methotrexate_v01.pdf">IE and Methotrexate</a></p>
<p><a href="/sites/default/files/sarcoma_ie_v01.pdf">IE</a></p>
<p><a href="/sites/default/files/sarcoma_ifosfamide_v01.pdf">Ifosfamide</a></p>
<p><a href="/sites/default/files/sarcoma_iva_v01.pdf">IVA</a></p>
<p><a href="/sites/default/files/sarcoma_ivado_and_iva_v01.pdf">IVADo - IVA</a></p>
<p><a href="/sites/default/files/sarcoma_map_v01.pdf">MAP</a></p>
<p><a href="/sites/default/files/sarcoma_mifamurtide_v01.pdf">Mifamurtide</a></p>
<p><a href="/sites/default/files/sarcoma_paclitaxel_v01.pdf">Paclitaxel</a></p>
<p><a href="/sites/default/files/sarcoma_pegylated_liposomal_doxorubicin_and_ifosfamide_v01.pdf">Pegylated Liposomal Doxorubicin and Ifosfamide</a></p>
<p><a href="/sites/default/files/sarcoma_pegylated_liposomal_doxorubicin_v01.pdf">Pegylated Liposomal Doxorubicin</a></p>
<p><a href="/sites/default/files/sarcoma_trabectedin_v01.pdf">Trabectedine</a></p>
<p><a href="/sites/default/files/sarcoma_va_v01.pdf">VA</a></p>
<p><a href="/sites/default/files/sarcoma_vac_v01.pdf">VAC</a></p>
<p><a href="/sites/default/files/sarcoma_vai_v01.pdf">VAI</a></p>
<p><a href="/sites/default/files/sarcoma_vdc_and_ie_v01.pdf">VDC and IE</a></p>
<p><a href="/sites/default/files/sarcoma_vide_v01.pdf">VIDE</a></p>
<p><a href="/sites/default/files/sarcoma_vincristine_and_cyclophosphamide_v01.pdf">Vincristine and Cyclophosphamide</a></p>
<p><a href="/sites/default/files/sarcoma_vinorelbine_and_cyclophosphamide_v01.pdf">Vinorelbine and Cyclophosphamide</a></p>
<p><a href="/sites/default/files/sarcoma_vinorelbine_oral_v01.pdf">Vinorelbine (Oral)</a></p>
<p><a href="/sites/default/files/sarcoma_vit_v01.pdf">VIT</a></p>
<p><span class="button"><a href="/sites/default/files/sact_consent_form_upload_for_sarcoma.zip">Download all Sarcoma forms</a></span></p>
<p>Last updated: 27 March 2024</p>
 
          </div>
        </div>

      </div>
    

      <div class="panel panel-default">

        <div class="panel-heading">

          <h2 class="panel-title" id="sact_conset24">
            <a data-toggle="collapse" class="collapsed" data-parent="#accordion-sact_conset" href="#collapsesact_conset24">

              Thyroid cancer            </a>
          </h2>

        </div>


        <div id="collapsesact_conset24" class="panel-collapse ">
          <div class="panel-body">
                         <p><a href="/sites/default/files/cancer-stats/thyroid_cabozantinib_v2/thyroid_cabozantinib_v2.pdf">Cabozantinib</a></p>
<p><a href="/sites/default/files/cancer-stats/thyroid_dabrafenib_and_trametinib_v1/thyroid_dabrafenib_and_trametinib_v1.pdf">Dabrafenib and Trametinib</a></p>
<p><a href="/sites/default/files/cancer-stats/thyroid_entrectinib_v1/thyroid_entrectinib_v1.pdf">Entrectinib</a></p>
<p><a href="/sites/default/files/cancer-stats/thyroid_larotrectinib_v1/thyroid_larotrectinib_v1.pdf">Larotrectinib</a></p>
<p><a href="/sites/default/files/cancer-stats/thyroid_lenvatinib_v2/thyroid_lenvatinib_v2.pdf">Lenvatinib</a></p>
<p><a href="/sites/default/files/cancer-stats/thyroid_selpercatinib_v1/thyroid_selpercatinib_v1.pdf">Selpercatinib</a></p>
<p><a href="/sites/default/files/cancer-stats/thyroid_sorafenib_v2/thyroid_sorafenib_v2.pdf">Sorafenib</a></p>
<p><a href="/sites/default/files/cancer-stats/thyroid_vendatinib_v2/thyroid_vendatinib_v2.pdf">Vandetanib</a></p>
<p><span class="button"><a href="/sites/default/files/thyroid-sact-04-22.zip">Download all thyroid cancer SACT forms</a></span></p>
<p>Last updated: 5 April 2022</p>
 
          </div>
        </div>

      </div>
    

      <div class="panel panel-default">

        <div class="panel-heading">

          <h2 class="panel-title" id="sact_conset25">
            <a data-toggle="collapse" class="collapsed" data-parent="#accordion-sact_conset" href="#collapsesact_conset25">

              Urology-Bladder cancer            </a>
          </h2>

        </div>


        <div id="collapsesact_conset25" class="panel-collapse ">
          <div class="panel-body">
                         <p><a href="/sites/default/files/atezolizumab_v2.pdf">Atezolizumab</a></p>
<p><a href="/sites/default/files/avelumab.pdf">Avelumab</a></p>
<p><a href="/sites/default/files/urology_bladder_accelerated_m-vac_methotrexate-vinblastine-doxorubicin-cisplatin_v03.pdf">Accelerated M-VAC (methotrexate-vinblastine-doxorubicin-cisplatin)</a></p>
<p><a href="/sites/default/files/urology_bladder_carboplatin_-_paclitaxel_v03.pdf">Carboplatin-Paclitaxel</a></p>
<p><a href="/sites/default/files/urology_bladder_gemcitabine_-_carboplatin_v03.pdf">Gemcitabine-Carboplatin</a></p>
<p><a href="/sites/default/files/urology_bladder_gemcitabine_-_cisplatin_v03.pdf">Gemcitabine-Cisplatin</a></p>
<p><a href="/sites/default/files/urology_bladder_gemcitabine_-_radiotherapy_v02.pdf">Gemcitabine-Radiotherapy</a></p>
<p><a href="/sites/default/files/urology_bladder_mitomycin-fluorouracil_-_radiotherapy_v03.pdf">Mitomycin-Fluorouracil +/- Radiotherapy</a></p>
<p><a href="/sites/default/files/nivolumab.pdf">Nivolumab</a></p>
<p><a href="/sites/default/files/urology_bladder_paclitaxel_v03.pdf">Paclitaxel</a></p>
<p><a href="/sites/default/files/pembrolizumab_v2.pdf">Pembrolizumab</a></p>
<p><span class="button"><a href="/sites/default/files/urology-bladder-cancers-sact-forms0208.zip">Download all urology-bladder cancers SACT forms</a></span></p>
<p>Last updated:28 January 2025</p>
 
          </div>
        </div>

      </div>
    

      <div class="panel panel-default">

        <div class="panel-heading">

          <h2 class="panel-title" id="sact_conset26">
            <a data-toggle="collapse" class="collapsed" data-parent="#accordion-sact_conset" href="#collapsesact_conset26">

              Urology-Germ cell cancer            </a>
          </h2>

        </div>


        <div id="collapsesact_conset26" class="panel-collapse ">
          <div class="panel-body">
                         <p><a href="/sites/default/files/urology_germ_cell_bep_v03.pdf">BEP (Bleomycin-Etoposide-Cisplatin)</a></p>
<p><a href="/sites/default/files/cancer-stats/urology_-_germ_cell_cancer_carboplatin_v2/urology_germ_cell_carboplatin_v03.pdf">Carboplatin</a></p>
<p><a href="/sites/default/files/cancer-stats/urology_-_germ_cell_cancer_carboplatin_-_etoposide_-_bleomycin_v1/urology_germ_cell_carboplatin_etoposide_and_bleomycin_v02.pdf">Carboplatin (Etoposide-Bleomycin)</a></p>
<p><a href="/sites/default/files/cancer-stats/urology_-_germ_cell_cancer_ep_etoposide-cisplatin_v2/urology_germ_cell_ep_v03.pdf">EP (Etoposide-Cisplatin)</a></p>
<p><a href="/sites/default/files/cancer-stats/urology_-_germ_cell_cancer_tip_paclitaxel-ifosfamide-cisplatin_v2/urology_germ_cell_tip_v03.pdf">TIP (Paclitaxel-Ifosfamide-Cisplatin)</a></p>
<p><a href="/sites/default/files/cancer-stats/urology_-_germ_cell_cancer_vip_etoposide-ifosfamide-cisplatin_v2/urology_-_germ_cell_cancer_vip_etoposide-ifosfamide-cisplatin_v2.pdf">VIP (Etoposide-Ifosfamide-Cisplatin)</a></p>
<p><a href="/sites/default/files/cancer-stats/urology_-_germ_cell_cancer_veip_vinblastine-ifosphamide-cisplatin_v2/urology_germ_cell_veip_v03.pdf">VeIP (Vinblastine-Ifosfamide-Cisplatin)</a></p>
<p><span class="button"><a href="/sites/default/files/urology_-_germ_cell_cancer_-_sact_forms.zip">Download all urology-germ cell cancer SACT forms</a></span></p>
<p>Last updated: 11 June 2024</p>
 
          </div>
        </div>

      </div>
    

      <div class="panel panel-default">

        <div class="panel-heading">

          <h2 class="panel-title" id="sact_conset27">
            <a data-toggle="collapse" class="collapsed" data-parent="#accordion-sact_conset" href="#collapsesact_conset27">

              Urology-Prostate cancer            </a>
          </h2>

        </div>


        <div id="collapsesact_conset27" class="panel-collapse ">
          <div class="panel-body">
                         <p><a href="/sites/default/files/cancer-stats/urology_prostate_abiraterone_prednisolone_v2/urology_prostate_abiraterone_prednisolone_v2.pdf">Abiraterone + Prednisolone</a></p>
<p><a href="/sites/default/files/cancer-stats/urology_prostate_apalutamide_v1/urology_prostate_apalutamide_v1.pdf">Apalutamide</a></p>
<p><a href="/sites/default/files/cancer-stats/urology_prostate_cabazitaxel_prednisolone_v2/urology_prostate_cabazitaxel_prednisolone_v2.pdf">Cabazitaxel + Prednisolone</a></p>
<p><a href="/sites/default/files/cancer-stats/urology_prostate_darolutamide_v1/urology_prostate_darolutamide_v1.pdf">Darolutamide</a></p>
<p><a href="/sites/default/files/urology_prostate_darolutamide_docetaxel_adt_v01.pdf"><span><span>Darolutamide and Docetaxel with ADT</span></span></a></p>
<p><a href="/sites/default/files/cancer-stats/urology_prostate_docetaxel_prednisolone_v2/urology_prostate_docetaxel_prednisolone_v2.pdf">Docetaxel + Prednisolone</a></p>
<p><a href="/sites/default/files/cancer-stats/urology_prostate_enzalutamide_v2/urology_prostate_enzalutamide_v2.pdf">Enzalutamide</a></p>
<p><a href="/sites/default/files/cancer-stats/urology_prostate_olaparib_v1/urology_prostate_olaparib_v1.pdf">Olaparib</a></p>
<p><span class="button"><a href="/sites/default/files/urology_prostate_all-sact-forms.zip">Download all urology-prostate cancerÂ SACT forms</a></span></p>
<p>Last updated: 13th May 2024</p>
 
          </div>
        </div>

      </div>
    

      <div class="panel panel-default">

        <div class="panel-heading">

          <h2 class="panel-title" id="sact_conset28">
            <a data-toggle="collapse" class="collapsed" data-parent="#accordion-sact_conset" href="#collapsesact_conset28">

              Urology-Renal cell cancer            </a>
          </h2>

        </div>


        <div id="collapsesact_conset28" class="panel-collapse ">
          <div class="panel-body">
                         <p><a href="/sites/default/files/cancer-stats/urology-renal_cell_generic_template_for_tki_io_v1/urology-renal_cell_generic_template_for_tki_io_v1.pdf">Generic TKI &amp; IO</a></p>
<p><a href="/sites/default/files/cancer-stats/urology-renal_cell_avelumab_and_axitinib_v1/urology-renal_cell_avelumab_and_axitinib_v1_0.pdf">Avelumab - Axitinib</a></p>
<p><a href="/sites/default/files/cancer-stats/urology-renal_cell_axitinib_v2/urology-renal_cell_axitinib_v2_0.pdf">Axitinib</a></p>
<p><a href="/sites/default/files/cancer-stats/urology-renal_cell_cabozanitinib_v2/urology-renal_cell_cabozanitinib_v2.pdf">Cabozantinib</a></p>
<p><a href="/sites/default/files/urology-renal_cell_everolimus_v2.pdf">Everolimus</a></p>
<p><a href="/sites/default/files/cancer-stats/urology-renal_cell_gemcitabine_-_doxorubicin_v2/urology-renal_cell_gemcitabine_-_doxorubicin_v2_0.pdf">Gemcitabine-Doxorubicin</a></p>
<p><a href="/sites/default/files/urology-renal_cell_lenvatinib_and_everolimus_v2.pdf">Lenvatinib-Everolimus</a></p>
<p><a href="/sites/default/files/urology-renal_cell_nivolumab_v2.pdf">Nivolumab</a></p>
<p><a href="/sites/default/files/cancer-stats/urology-renal_cell_nivolumab_-_ipilimumab_v1/urology-renal_cell_nivolumab_-_ipilimumab_v1_0.pdf">Nivolumab - Ipilimumab</a></p>
<p><a href="/sites/default/files/urology_renal_cell_carcinoma_pazopanib_v02.pdf">Pazopanib</a></p>
<p><a href="/sites/default/files/urology-renal_cell_pembrolizumab_v01.pdf">Pembrolizumab</a></p>
<p><a href="/sites/default/files/cancer-stats/urology-renal_cell_sunitinib_v2/urology-renal_cell_sunitinib_v2_0.pdf">Sunitinib</a></p>
<p><a href="/sites/default/files/cancer-stats/urology-renal_cell_tivozanib_v2/urology-renal_cell_tivozanib_v2_0.pdf">Tivozanib</a></p>
<p><span class="button"><a href="/sites/default/files/urology-renal_cell_all-sact-forms-december-2023.zip">Download allÂ Urology-Renal cell cancer SACT forms</a></span></p>
<p>Last updated: 7th December 2023</p>
 
          </div>
        </div>

      </div>
    

      <div class="panel panel-default">

        <div class="panel-heading">

          <h2 class="panel-title" id="sact_conset29">
            <a data-toggle="collapse" class="collapsed" data-parent="#accordion-sact_conset" href="#collapsesact_conset29">

              Urology-Small cell cancer            </a>
          </h2>

        </div>


        <div id="collapsesact_conset29" class="panel-collapse ">
          <div class="panel-body">
                         <p><a href="/sites/default/files/urology_small_cell_carboplatin_etoposide_v2.pdf">Carboplatin-Etoposide</a></p>
<p><a href="/sites/default/files/urology_small_cell_cisplatin_etoposide_v2.pdf">Cisplatin-Etoposide</a></p>
<p><span class="button"><a href="/sites/default/files/urology_small_cell_all-sact-forms.zip">Download allÂ Urology-SmallÂ cell cancer SACT forms</a></span></p>
<p><span class="button">Last updated: 10 August 2021</span></p>
 
          </div>
        </div>

      </div>
    

      <div class="panel panel-default">

        <div class="panel-heading">

          <h2 class="panel-title" id="sact_conset30">
            <a data-toggle="collapse" class="collapsed" data-parent="#accordion-sact_conset" href="#collapsesact_conset30">

              Skin cancer (non-melanoma)            </a>
          </h2>

        </div>


        <div id="collapsesact_conset30" class="panel-collapse ">
          <div class="panel-body">
                         <p><a href="/sites/default/files/non_melanoma_skin_cancer_alemtuzumab_v1.pdf">Alemtuzumab</a></p>
<p><a href="/sites/default/files/nmsc_avelumab_v02.pdf">Avelumab</a></p>
<p><a href="/sites/default/files/non_melanoma_skin_cancer_bexarotene_v1.pdf">Bexarotene</a></p>
<p><a href="/sites/default/files/nmsc_carboplatin_etoposide_v02.pdf">Carboplatin-Etoposide</a></p>
<p><a href="/sites/default/files/nmsc_capecitabine_and_cisplatin_v02.pdf">Capecitabine-Cisplatin</a></p>
<p><a href="/sites/default/files/nmsc_cemiplimab_v01.pdf">Cemiplimab</a></p>
<p><a href="/sites/default/files/non_melanoma_skin_cancer_chlorambucil-prednisolone_v1.pdf">Chlorambucil +/- Prednisolone</a></p>
<p><a href="/sites/default/files/non_melanoma_skin_cancer_chop_21_v1.pdf">CHOP 21</a></p>
<p><a href="/sites/default/files/non_melanoma_skin_cancer_chop_21rituximab_chop-r_v1.pdf">CHOP 21 + Rituximab (CHOP-R)</a></p>
<p><a href="/sites/default/files/nmsc_cisplatin_and_fluorouracil_v02.pdf">Cisplatin-Fluorouracil</a></p>
<p><a href="/sites/default/files/non_melanoma_skin_cancer_cvp_v1.pdf">CVP (Cyclophosphamide-Vincristine-Prednisolone)</a></p>
<p><a href="/sites/default/files/nmsc_epirubicin_v02.pdf">Epirubicin</a></p>
<p><a href="/sites/default/files/non_melanoma_skin_cancer_etoposide_oral_v1.pdf">Etoposide (Oral)</a></p>
<p><a href="/sites/default/files/non_melanoma_skin_cancer_gemcitabine_v1.pdf">Gemcitabine</a></p>
<p><a href="/sites/default/files/non_melanoma_skin_cancer_interferon-alfa_2a_v1.pdf">Interferon alfa-2a (Roferon-AÂ®)</a></p>
<p><a href="/sites/default/files/non_melanoma_skin_cancer_liposomal_doxorubicin_v1.pdf">Liposomal Doxorubicin (CaelyxÂ®)</a></p>
<p><a href="/sites/default/files/non_melanoma_skin_cancer_methotrexate_oral_v1.pdf">Methotrexate (Oral)</a></p>
<p><a href="/sites/default/files/non_melanoma_skin_cancer_pentostatin_v1.pdf">Pentostatin</a></p>
<p><a href="/sites/default/files/non_melanoma_skin_cancer_rituximab_v1.pdf">Rituximab</a></p>
<p><a href="/sites/default/files/nmsc_vismodegib_v01.pdf">Vismodegib</a><br>
Â </p>
<p><span class="button"><a href="/sites/default/files/non-melanoma_skin_cancer_new.zip">Download all skin cancer (non-melanoma) SACT forms</a></span></p>
<p><span class="button">Last updated: 15 March 2024</span></p>
 
          </div>
        </div>

      </div>
    

      <div class="panel panel-default">

        <div class="panel-heading">

          <h2 class="panel-title" id="sact_conset31">
            <a data-toggle="collapse" class="collapsed" data-parent="#accordion-sact_conset" href="#collapsesact_conset31">

              Supportive medicines            </a>
          </h2>

        </div>


        <div id="collapsesact_conset31" class="panel-collapse ">
          <div class="panel-body">
                         <p><a href="/sites/default/files/supportive_medicines_denosumab_v2.pdf">Denosumab (XgevaÂ®)</a></p>
<p><a href="/sites/default/files/supportive_medicines_zolendronic_acid_v2.pdf">Zoledronic acid</a></p>
<p><span class="button"><a href="/sites/default/files/supportive-medicines-updated.zip">Download all supportive medicines forms</a></span></p>
<p>Last updated: 07 August 2020</p>
 
          </div>
        </div>

      </div>
    
  
</div>
</div>


</div>
      </div>
    </div>
  

  <div id="panel-row-1" class="panel-row panel-related-row">
    
      </div>


      <div id="panel-6" class="col-md-12 col-sm-12 col-xs-12">
      <div class="panel-content">
        
<div class="panel-pane pane-fieldable-panels-pane pane-uuid-35e98ed1-211c-4505-9aeb-41a2304e4e9b pane-bundle-fieldable-panels-pane pane-promo">
  
      <h2 class="pane-title">
  Publishing, additions and updates</h2>



<div class="pane-content">
  <div class="fieldable-panels-pane">
    

<div class="field field-type-text-with-summary">
  
  
                <div class="field-item"> <p>We are publishing forms by tumour site, the first were for breast cancer in May 2016. We will publish new forms for other tumour sites regularly.</p>
<p>Recent additions and updates will be highlighted on the "What's new?" section on this page, and details of when forms have been last updated is stated in each section. Please check for updated versions and ensure that you use the latest version of each form.</p>
 </div>
        </div>
</div>
</div>


</div>
<div class="panel-separator"></div>
<div class="panel-pane pane-fieldable-panels-pane pane-uuid-2c7132c1-a945-48f8-a36c-1b457148f892 pane-bundle-fieldable-panels-pane pane-promo">
  
      <h2 class="pane-title">
  Join us on X (previously known as Twitter)</h2>



<div class="pane-content">
  <div class="fieldable-panels-pane">
    

<div class="field field-type-text-with-summary">
  
  
                <div class="field-item"> <table border="0" cellpadding="10" cellspacing="10">
<tr>
<td>
<h3>Join the conversation and follow @CRUKHCPs for news, updates and opinion.</h3>
</td>
<td>
<p><span class="button"><a href="https://twitter.com/crukhcps" target="_blank">@CRUKHCPs</a></span></p>
</td>
</tr>
</table>
 </div>
        </div>
</div>
</div>


</div>
<div class="panel-separator"></div><div class="panel-pane pane-fieldable-panels-pane pane-uuid-38c6c166-4ef3-403e-a702-09812be10e7a pane-promo grey-panel">
  
        <h2 class="pane-title">See also</h2>
    
  
  <div class="pane-content">
    <div class="fieldable-panels-pane">
    

<div class="field field-type-text-with-summary">
  
  
                <div class="field-item"> <p><a href="http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(16)30383-7/fulltext">Read a world first population based study of 30-day mortality following SACT in England</a></p>
<p><a href="http://scienceblog.cancerresearchuk.org/2016/08/31/new-data-on-cancer-treatment-to-help-improve-care/">Read our blog on the studyâs findings and how the work will help improve patient case</a></p>
<p><a href="https://www.gov.uk/government/news/new-findings-on-post-chemotherapy-deaths-using-world-first-phe-cancer-data">View the NHS Trust and national SACT 30-day mortality data published by Public Health England</a></p>
 </div>
        </div>
</div>
  </div>

  
  </div>
      </div>
    </div>
  
  <div id="panel-row-2" class="panel-row panel-related-row">
    
      </div>


  
  <div id="panel-row-3" class="panel-row panel-related-row">
      
        </div>

  <div id="panel-row-4" class="panel-row panel-related-row">
    
    
      </div>


  <div id="panel-row-5" class="panel-row panel-related-row">
    
      
        </div>

  <div id="panel-row-6" class="panel-row panel-related-row">
    
    
      </div>

  
  
  
  
  
  
  </div>
  
            <div id="mobile-nav"></div>
     <!-- end of main content -->
    </main>

    
    
  </div><!-- #wrapper -->
</div>

<footer role="contentinfo">
  <div class="container">
    <div class="footer-links">
      <div class="footer-links__list">
        <h2>Speak to a nurse</h2>
        <ul>
          <li><a href="tel://0808%20800%204040">Nurse Helpline<br>0808 800 4040</a></li>
          <li>Questions about cancer? Call freephone<br>9 to 5 Monday to Friday or <a href="/about-us/contact-us/talk-to-our-nurses?secure=true">email us</a></li>
        </ul>
      </div>

      <div class="footer-links__list">
        <h2>Quick links</h2><ul class="links"><li class="0 first"><a href="/get-involved/find-a-shop">Find local shops</a></li>
<li class="1"><a href="https://shop.cancerresearchuk.org/?utm_source=cruk_footer">Shop online</a></li>
<li class="2"><a href="/about-us/contact-us">Contact us</a></li>
<li class="3 last"><a href="/about-us/charity-jobs">Jobs</a></li>
</ul>      </div>

      <div class="footer-links__icons">
        <h2>Follow us</h2>
        <ul>
          <li>
            <a href="https://www.facebook.com/cancerresearchuk/">
              <img src="/sites/all/themes/custom/cruk/images/social_icons/facebook_icon.svg" width="40" height="40" alt="Like Cancer Research UK on Facebook">
            </a>
          </li>
          <li>
            <a href="https://twitter.com/CR_UK">
              <img src="/sites/all/themes/custom/cruk/images/social_icons/twitter_icon.svg" width="40" height="40" alt="Follow Cancer Research UK on Twitter">
            </a>
          </li>
          <li>
            <a href="https://www.instagram.com/cr_uk/">
              <img src="/sites/all/themes/custom/cruk/images/social_icons/instagram_icon.svg" width="40" height="40" alt="Follow Cancer Research UK on Instagram">
            </a>
          </li>
          <li>
            <a href="https://www.linkedin.com/company/cancer-research-uk/">
              <img src="/sites/all/themes/custom/cruk/images/social_icons/linkedin_icon.svg" width="40" height="40" alt="Connect with Cancer Research UK on LinkedIn">
            </a>
          </li>
          <li>
            <a href="https://www.youtube.com/user/cancerresearchuk">
              <img src="/sites/all/themes/custom/cruk/images/social_icons/youtube_icon.svg" width="40" height="40" alt="Subscribe to Cancer Research UK on YouTube">
            </a>
          </li>
        </ul>
      </div>
    </div>

    <div class="footer-links">
      <div class="footer-links__list--horizontal">
        <ul class="links"><li class="0 first"><a href="/about-cancer/about-our-information">About our information</a></li>
<li class="1"><a href="/about-us/utilities/terms-and-conditions">Terms and conditions</a></li>
<li class="2"><a href="/about-us/utilities/privacy-statement">Privacy</a></li>
<li class="3"><a href="/modern-slavery-transparency-statement">Modern Slavery Statement</a></li>
<li class="4"><a href="/about-us/utilities/cookies-policy">Cookies</a></li>
<li class="5"><a href="/about-us/utilities/accessibility">Accessibility</a></li>
<li class="6 last"><a href="/sitemap">Sitemap</a></li>
</ul>      </div>
    </div>

    <div id="awards" class="footer-secondary-content">
      <a href="https://www.fundraisingregulator.org.uk/"><img src="/sites/all/themes/custom/cruk/images/fund-reg.svg" alt="Registered with Fundraising Regulator (logo)" width="165" height="52"></a>
    </div>

    <address class="footer-secondary-content">Cancer Research UK is a registered charity in England and Wales (1089464), Scotland (SC041666), the Isle of Man (1103) and Jersey (247). A company limited by guarantee. Registered company in England and Wales (4325234) and the Isle of Man (5713F). Registered address: 2 Redman Place, London, E20 1JQ.</address>
  </div>
</footer>
<script src="https://www.cancerresearchuk.org/sites/all/libraries/modernizr/modernizr-3.3.1.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/contrib/jquery_update/replace/jquery/2.1/jquery.min.js?v=2.1.4"></script>
<script>jQuery.migrateMute=true;jQuery.migrateTrace=false;</script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/contrib/jquery_update/replace/jquery-migrate/1/jquery-migrate.min.js?v=1"></script>
<script src="https://www.cancerresearchuk.org/misc/jquery-extend-3.4.0.js?v=2.1.4"></script>
<script src="https://www.cancerresearchuk.org/misc/jquery-html-prefilter-3.5.0-backport.js?v=2.1.4"></script>
<script src="https://www.cancerresearchuk.org/misc/jquery.once.js?v=1.2"></script>
<script src="https://www.cancerresearchuk.org/misc/drupal.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/contrib/jquery_update/replace/ui/ui/minified/jquery.ui.core.min.js?v=1.10.2"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/contrib/jquery_update/replace/ui/ui/minified/jquery.ui.widget.min.js?v=1.10.2"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/contrib/jquery_update/replace/ui/external/jquery.cookie.js?v=67fb34f6a866c40d0570"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/contrib/jquery_update/replace/ui/ui/minified/jquery.ui.position.min.js?v=1.10.2"></script>
<script src="https://www.cancerresearchuk.org/misc/ui/jquery.ui.position-1.13.0-backport.js?v=1.10.2"></script>
<script src="https://www.cancerresearchuk.org/misc/ajax.js?v=7.103"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/contrib/jquery_update/js/jquery_update.js?v=0.0.1"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/custom/clientside_validation_rule_pword_match/js/clientside_validation_rule_pword_match.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/custom/cruk_donate/js/cruk_donate.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/custom/cruk_gc_timeline/js/jquery.kinetic.min.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/custom/cruk_gc_timeline/js/timeline.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/contrib/entityreference/js/entityreference.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/contrib/geofield_gmap/geofield_gmap.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/contrib/resp_img/resp_img.js?" class="optanon-category-fun cruk-onetrust-blocked-scripts"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/custom/cruk_core_info/js/cruk_core_info.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/custom/cruk_core_info/js/clipboard.min.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/custom/cruk_image_gallery/js/slick.min.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/custom/cruk_shine_night_walks/js/select-styling.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/custom/cruk_config_fieldable_panels/js/cruk_config_fieldable_panels_geolocation.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/custom/cruk_donate/selectmenu/jquery.ui.selectmenu.js?v=1.3.0"></script>
<script src="https://www.cancerresearchuk.org/misc/progress.js?v=7.103"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/custom/cruk_onetrust/js/crukOneTrustPlaceholder.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/custom/cruk_onetrust/js/crukOneTrustDynatrace.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/custom/cruk_onetrust/js/crukOneTrustRefreshBlockedScripts.js?"></script>
<script src="https://platform.twitter.com/widgets.js" class="optanon-category-tar cruk-onetrust-blocked-scripts"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/custom/cruk_taxonomy_glossary/js/cruk_taxonomy_glossary.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/contrib/extlink/js/extlink.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/vendor/bootstrap/bootstrap/collapse.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/vendor/bootstrap/bootstrap/dropdown.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/vendor/bootstrap/bootstrap/transition.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/vendor/bootstrap/bootstrap/carousel.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/vendor/packery.pkgd.min.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/vendor/slick.min.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/vendor/pure.min.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/vendor/jquery.mobile.custom.min.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/vendor/media.match.min.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/vendor/enquire.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/vendor/ios-orientationchange-fix.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/console.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/tabs_to_accordion.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/cruk-accordion.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/jquery.megamenu.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/script.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/jquery.mobile-rebrand.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/interactive_timeline.js?"></script>
<script>jQuery.extend(Drupal.settings, {"basePath":"\/","pathPrefix":"","setHasJsCookie":0,"ajaxPageState":{"theme":"cruk","theme_token":"ZSdckI8JvJ6TCrEs4GosZ7EjuOyocIhmWHIAc1Eaa-k","jquery_version":"2.1","js":{"sites\/all\/modules\/custom\/cruk_image_gallery\/js\/cruk_image_gallery.js":1,"0":1,"sites\/all\/libraries\/modernizr\/modernizr-3.3.1.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/jquery\/2.1\/jquery.min.js":1,"1":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/jquery-migrate\/1\/jquery-migrate.min.js":1,"misc\/jquery-extend-3.4.0.js":1,"misc\/jquery-html-prefilter-3.5.0-backport.js":1,"misc\/jquery.once.js":1,"misc\/drupal.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.core.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.widget.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/external\/jquery.cookie.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.position.min.js":1,"misc\/ui\/jquery.ui.position-1.13.0-backport.js":1,"misc\/ajax.js":1,"sites\/all\/modules\/contrib\/jquery_update\/js\/jquery_update.js":1,"sites\/all\/modules\/custom\/clientside_validation_rule_pword_match\/js\/clientside_validation_rule_pword_match.js":1,"sites\/all\/modules\/custom\/cruk_donate\/js\/cruk_donate.js":1,"sites\/all\/modules\/custom\/cruk_gc_timeline\/js\/jquery.kinetic.min.js":1,"sites\/all\/modules\/custom\/cruk_gc_timeline\/js\/timeline.js":1,"sites\/all\/modules\/contrib\/entityreference\/js\/entityreference.js":1,"sites\/all\/modules\/contrib\/geofield_gmap\/geofield_gmap.js":1,"sites\/all\/modules\/contrib\/resp_img\/resp_img.js":1,"sites\/all\/modules\/custom\/cruk_core_info\/js\/cruk_core_info.js":1,"sites\/all\/modules\/custom\/cruk_core_info\/js\/clipboard.min.js":1,"sites\/all\/modules\/custom\/cruk_image_gallery\/js\/slick.min.js":1,"sites\/all\/modules\/custom\/cruk_shine_night_walks\/js\/select-styling.js":1,"sites\/all\/modules\/custom\/cruk_config_fieldable_panels\/js\/cruk_config_fieldable_panels_geolocation.js":1,"sites\/all\/modules\/custom\/cruk_donate\/selectmenu\/jquery.ui.selectmenu.js":1,"misc\/progress.js":1,"sites\/all\/modules\/custom\/cruk_onetrust\/js\/crukOneTrustPlaceholder.js":1,"sites\/all\/modules\/custom\/cruk_onetrust\/js\/crukOneTrustDynatrace.js":1,"sites\/all\/modules\/custom\/cruk_onetrust\/js\/crukOneTrustRefreshBlockedScripts.js":1,"https:\/\/platform.twitter.com\/widgets.js":1,"sites\/all\/modules\/custom\/cruk_taxonomy_glossary\/js\/cruk_taxonomy_glossary.js":1,"sites\/all\/modules\/contrib\/extlink\/js\/extlink.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/vendor\/bootstrap\/bootstrap\/collapse.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/vendor\/bootstrap\/bootstrap\/dropdown.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/vendor\/bootstrap\/bootstrap\/transition.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/vendor\/bootstrap\/bootstrap\/carousel.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/vendor\/packery.pkgd.min.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/vendor\/slick.min.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/vendor\/pure.min.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/vendor\/jquery.mobile.custom.min.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/vendor\/media.match.min.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/vendor\/enquire.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/vendor\/ios-orientationchange-fix.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/console.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/tabs_to_accordion.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/cruk-accordion.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/jquery.megamenu.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/script.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/jquery.mobile-rebrand.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/interactive_timeline.js":1},"css":{"modules\/system\/system.base.css":1,"modules\/system\/system.menus.css":1,"modules\/system\/system.messages.css":1,"modules\/system\/system.theme.css":1,"0":1,"misc\/ui\/jquery.ui.core.css":1,"misc\/ui\/jquery.ui.theme.css":1,"modules\/aggregator\/aggregator.css":1,"sites\/all\/modules\/custom\/cruk_gc_timeline\/css\/grand_challenge_timeline.css":1,"modules\/field\/theme\/field.css":1,"sites\/all\/modules\/contrib\/geofield_gmap\/geofield_gmap.css":1,"modules\/node\/node.css":1,"modules\/search\/search.css":1,"modules\/user\/user.css":1,"sites\/all\/modules\/contrib\/extlink\/css\/extlink.css":1,"sites\/all\/modules\/contrib\/views\/css\/views.css":1,"sites\/all\/modules\/contrib\/ckeditor\/css\/ckeditor.css":1,"sites\/all\/modules\/contrib\/ctools\/css\/ctools.css":1,"sites\/all\/modules\/contrib\/panels\/css\/panels.css":1,"sites\/all\/themes\/custom\/cruk\/layouts\/landing_page_kids_and_teens\/landing_page_kids_and_teens.css":1,"sites\/all\/modules\/custom\/cruk_donate\/selectmenu\/jquery.ui.selectmenu.css":1,"sites\/all\/modules\/contrib\/node_embed\/plugins\/node_embed\/node_embed.css":1,"sites\/all\/modules\/custom\/cruk_taxonomy_glossary\/css\/cruk_taxonomy_glossary.css":1,"sites\/all\/themes\/contrib\/mothership\/mothership\/css\/reset.css":1,"sites\/all\/themes\/contrib\/mothership\/mothership\/css\/reset-html5.css":1,"sites\/all\/themes\/contrib\/mothership\/mothership\/css\/mothership-default.css":1,"sites\/all\/themes\/contrib\/mothership\/mothership\/css\/mothership.css":1,"sites\/all\/themes\/custom\/cruk\/css\/tabs_to_accordion.css":1,"sites\/all\/themes\/custom\/cruk\/css\/style.css":1,"sites\/all\/themes\/custom\/cruk\/css\/cruk.menus.css":1,"sites\/all\/themes\/custom\/cruk\/css\/mobile.menu.css":1,"sites\/all\/themes\/custom\/cruk\/css\/slick.css":1,"sites\/all\/themes\/custom\/cruk\/css\/content_panel.css":1,"sites\/all\/themes\/custom\/cruk\/css\/scroller.css":1,"sites\/all\/themes\/custom\/cruk\/normalize.css":1,"sites\/all\/themes\/custom\/cruk\/reset.css":1,"sites\/all\/themes\/custom\/cruk\/reset-html5.css":1,"sites\/all\/themes\/custom\/cruk\/mothership.css":1,"sites\/all\/themes\/custom\/cruk\/mothership-default.css":1,"sites\/all\/themes\/custom\/cruk\/mothership-devel-mediaqueries.css":1,"sites\/all\/themes\/custom\/cruk\/css\/print.css":1,"public:\/\/css_injector\/css_injector_31.css":1,"public:\/\/css_injector\/css_injector_131.css":1,"public:\/\/css_injector\/css_injector_156.css":1,"public:\/\/css_injector\/css_injector_196.css":1,"public:\/\/css_injector\/css_injector_201.css":1,"public:\/\/css_injector\/css_injector_206.css":1,"public:\/\/css_injector\/css_injector_211.css":1,"public:\/\/css_injector\/css_injector_226.css":1,"public:\/\/css_injector\/css_injector_241.css":1,"public:\/\/css_injector\/css_injector_251.css":1,"public:\/\/css_injector\/css_injector_261.css":1,"public:\/\/css_injector\/css_injector_276.css":1,"public:\/\/css_injector\/css_injector_281.css":1,"public:\/\/css_injector\/css_injector_291.css":1,"public:\/\/css_injector\/css_injector_296.css":1,"public:\/\/css_injector\/css_injector_306.css":1,"public:\/\/css_injector\/css_injector_361.css":1,"public:\/\/css_injector\/css_injector_371.css":1,"public:\/\/css_injector\/css_injector_376.css":1,"public:\/\/css_injector\/css_injector_426.css":1,"public:\/\/css_injector\/css_injector_441.css":1,"public:\/\/css_injector\/css_injector_456.css":1,"public:\/\/css_injector\/css_injector_466.css":1,"public:\/\/css_injector\/css_injector_471.css":1,"public:\/\/css_injector\/css_injector_516.css":1,"public:\/\/css_injector\/css_injector_561.css":1,"public:\/\/css_injector\/css_injector_576.css":1,"public:\/\/css_injector\/css_injector_581.css":1,"public:\/\/css_injector\/css_injector_610.css":1,"public:\/\/css_injector\/css_injector_616.css":1,"public:\/\/css_injector\/css_injector_617.css":1,"public:\/\/css_injector\/css_injector_619.css":1,"public:\/\/css_injector\/css_injector_620.css":1}},"respImg":{"default_suffix":"_breakpoint_one","current_suffix":false,"forceRedirect":"0","forceResize":"1","reloadOnResize":"0","useDevicePixelRatio":1,"suffixes":{"_breakpoint_two":640,"_breakpoint_three":480,"_breakpoint_four":320,"_breakpoint_one":1}},"extlink":{"extTarget":"_blank","extClass":"external","extLabel":"(link is external)","extImgClass":0,"extIconPlacement":0,"extSubdomains":1,"extExclude":"(twitter\\.com|facebook\\.com|addthis\\.com|cancerresearchuk\\.org|cruk\\.org|cruk01)","extInclude":"https:\/\/www.cancerresearchuk.org\/(sites\/default\/files\/*)","extCssExclude":".social-link,.ignore-external,.navbar,.cruk-nav,.footer-social,.about-cancer-footer-icons,.pane-node-field-landing-key-message","extCssExplicit":"","extAlert":0,"extAlertText":"This link will take you to an external web site.","mailtoClass":0,"mailtoLabel":"(link sends e-mail)","extUseFontAwesome":0}});</script>

      
<script src="https://www.cancerresearchuk.org/sites/all/modules/custom/cruk_image_gallery/js/cruk_image_gallery.js?"></script>
<script>
  function OptanonWrapper() {

    crukOneTrustUpdatePlaceholders();

    crukOneTrustUpdateDynatrace();

    crukOneTrustRefreshBlockedScripts();
}</script>
</body>
</html>
